Forgot your password?
Document Actions
Speakers
Jeremy Adelman
( Associate Director of Advancement, The George Washington University )
Talking Points
At George Washington University, alumni are becoming "angel investors", making personal investment in early stage companies. By matching alumni investors with faculty, student and alumni-run companies, the value creation stays within George Washington and sets the stage for significant gifts to the University, equity in the new company, and commercialization of technologies developed in University labs. This type of activity engages some of the most affluent members of the alumni body in a sustained and often lucrative way. As a result, our alumni come back and remain committed to our school.
Bio
Jeremy L. Adelman is the Associate Director of Advancement at The George Washington University’s School of Engineering and Applied Science. During the 10 years he has spent as a manager and fundraiser in universities and nonprofit organizations, he has worked primarily with high tech business leaders and entrepreneurs as volunteers and donors. Notable accomplishments have been building an alumni angel investors network, and bringing in multiple million dollar donations from corporations and individuals. Mr. Adelman holds both an MBA from the Heller School of Social Policy and Management, and an MA in Nonprofit Professional Leadership from Brandies University, as well as a BA in Philosophy from the University of Utah.
_______________________
Paul Ahlstrom
( vSpring Venture Capital )
_______________________
Anna Amar
( NIAID, NIH )
Talking Points
Other than its own published research, the National Institutes of Health (NIH) is perhaps best known for funding biomedical studies through grants and contracts. However, when looking to NIH as a resource – the 27 institutes and centers that make up the NIH have an extensive collection of hidden “treasures” that are often available to both non-profit and for-profit organizations. NIH is making available these resources with the goal of assisting in the development of the environments and tools needed to understand, detect, treat, and prevent a wide range of diseases in order to better public health. The many materials and services that are accessible include:
Bio
Anna Z. Amar is currently the Lead Technology Development Associate for the Extramural Technology Development and Transfer Branch of the Office of Technology Development (OTD), National Institute of Allergy and Infectious Diseases (NIAID) at NIH. Anna joined OTD in January, 2003, having come from the Laboratory of Immunology, NIAID, where she had held a research position since 1995. Anna received her B.S. (Hons.) from Murdoch University in Australia, where she also undertook post-graduate training and was employed in the fields of immunology and molecular biology. While continuing her Ph.D. research in the States, she worked in the Laboratory of Molecular Genetics at the University of South Florida. Anna has been an active member of the NIH Technology Development Coordinator’s (TDC) Community having chaired the TDC Training Working Group, the NIAID Agreements for Clinical Trials Working Group, and having participated in the TDC Marketing Working Group as well as the Training and Education Subcommittee of the Technology Transfer Policy Board. Anna has recently been invited to speak at such forums as the Biotechnology Industry Organization (BIO) Convention and the American Conference Institute (ACI).
_______________________
Ali Andalibi
( Program Director, SBIR/STTR, National Science Foundation - NSF )
Talking Points
Our nation’s universities are the often the birthplaces of transformative ideas that can be of great benefit to society. Too often however, the flow of these important discoveries towards the marketplace is slow and indeed many times, the discoveries never leave the university. The goal of this conference is to bring together university decision-makers and members of the investment community, in addition to federal and state representatives in order to find ways of accelerating the movement university-based findings from laboratories into start-ups.
Bio
Dr. Ali Andalibi is a molecular biologist and geneticist by training with extensive experience in both academia and industry. He received his PhD from the UCLA department of Microbiology and Molecular Genetics and later joined the faculty in the UCLA department of Medicine. After leaving UCLA he was involved in several early stage biotechnology companies. He then joined the House Ear Institute (HEI), where he is the Director of New Technology and Project Development. He is also an adjunct Assistant Professor of Otolaryngology, at the University of Southern California, School of Medicine. Dr. Andalibi is currently on leave from HEI/USC and serving as a Program Director at the National Science Foundation.
_______________________
Meg Arnold
( Director, Business Development & Entrepreneurship, UC Davis InnovationAccess )
Talking Points
At UC Davis, as at a growing number of universities across the country, we actively seek to foster entrepreneurship across the campus, among faculty, graduate students and post-docs in the full range of disciplines. The UC Davis Center for Entrepreneurship at the Graduate School of Management has developed innovative approaches to integrating graduate-level scientists and MBA students into a year-long study of commercialization and entrepreneurship. In addition, administrative units including UC Davis InnovationAccess provide other services focused on entrepreneurship. This model of close collaboration and cooperation among different units is representative of the inter-disciplinary approach to research and education at UC Davis.
Bio
Meg Arnold is the Director of Business Development & Entrepreneurship at UC Davis InnovationAccess, and has developed numerous programs to foster entrepreneurship on campus and in the Sacramento region. Meg came to UC Davis in 2002 as Manager, Entrepreneur Development at UC Davis CONNECT, and was promoted to Director, UC Davis CONNECT in 2005. In March, 2007, UC Davis CONNECT became UC Davis InnovationAccess, in an expansion of UC Davis's commitment to entrepreneurship on campus. Reflecting this commitment, a fundamental shift in UC Davis’s approach to startup companies and entrepreneurship has generated nearly 20 new start-up companies from research activities underway on campus. Before joining UC Davis, Meg spent ten years in the telecommunications industry, working primarily in strategic planning and business development for AT&T Canada, in Toronto, and British Telecom (BT), in London. In these roles, her work focused on mergers and acquisitions, strategic and joint ventures; in addition, at BT she worked to coordinate a single product platform for Internet-based business services across Europe. She was also involved with the then-largest telecom acquisition in Canada, and the corporate restructuring and spin-off program of BT in 2001-02. Meg has an MBA in Finance from the University of San Francisco, and a BA in English from Cornell University.
_______________________
Daniel Behr
( Director Business Development, Harvard )
Talking Points
How to be an effective "venture catalyst" within the university setting; How to address the commercialization / funding gap.
Bio
Daniel Behr co-founded 4 technology companies, was a general partner in a seed-stage venture fund, and serves as director/advisor to several start-ups. He is currently a “venture catalyst” at Harvard University where he is Director of Business Development in the Office of Technology Development. Daniel was co-founder of IN USA which became a $10M world leader in ozone instrumentation; Compact Instruments, which developed the world’s first hand-held mass spectrometer and was acquired by MKS Instruments (NASDAQ:MKSI) in 2000; Arradiance, which is developing an electron-beam source for use in semiconductor lithography (funded by top-tier VC funds in November 2004); and Growth Point Life Sciences, a firm focused on accelerating the commercialization of intellectual property assets. His seed-stage angel fund, Seed Partners, was founded in 1999 and is fully invested in a portfolio of start-up companies. Daniel is a Director of Nutfield Technology (industrial lasers) and an advisor to companies commercializing new medical devices, instruments, nano technologies, and software products. Daniel earned an MBA with Distinction from the Harvard Business School and an engineering degree with Highest Honors from Georgia Tech, and is fluent in Spanish and German.
_______________________
Rob Bettigole
( Managing Partner, Elm Street Ventures )
Talking Points
Key catalysts for successful technology-based start-ups are the involvement of seasoned management and access to professional investment capital. Elm St Ventures is a seed and early stage venture fund, primarily (but not exclusively) focused on the life sciences. Our partners have substantial experience in starting, funding, and operating companies, and as we approach early stage investing as a hands-on undertaking, we prefer to fund businesses located within roughly an hour and a half’s drive of our office.
Bio
Rob Bettigole has broad experience as an entrepreneur and as a venture capitalist. His venture capital experience was gained as a partner at Rothschild Inc. and Investor AB, where his investments included Maxim Integrated Products, Gensia Pharmaceuticals, and Microgenics Corporation. Subsequently, he helped found Surety Technologies, Inc., a spin out from Bellcore, and Alexion (NASDAQ: ALXN), with researchers from the Yale Medical School. Before founding Elm Street, Mr. Bettigole was president of a business serving the infrastructure (bridge and highway) market, which he successfully developed and sold. Mr. Bettigole has a BS in Engineering and Applied Science from Yale University and an MPPM from the Yale School of Management, where he is an Entrepreneur-in-Residence. He is a Licensed Professional Engineer and holds several U.S. and foreign patents.
_______________________
Jack Biddle
( Co-founder, Novak Biddle Venture Partners )
Talking Points
For seasoned venture capitalists who understand both the science and the art of building a company around an idea, universities can provide excellent deal opportunities. However, several variables come into play that influence a start-up’s attractiveness including scalability, market opportunity, and potential dual use of a technology. My comments will focus on NBVP’s strategy for determining which start-ups are appealing from a VC’s perspective and why we pass on other opportunities.
Bio
Jack co-founded Novak Biddle Venture Partners in 1996. From 1990 to 1995 he was President and CEO of InterCAP, a venture backed computer software company with 100 Fortune 500 clients. InterCAP was number 18 on the "Fast 50" list of the mid-Atlantic's fastest growing companies. It was profitably acquired by Intergraph in 1995. From 1987 to 1990, Jack rose from Senior Associate to Partner at Vanguard Atlantic, Ltd., a merchant banking group focused on M&A advisory work and control investments in software companies on the firms own account. At VAL, he served as CEO or COO of several portfolio companies. Earlier in his career he was an IT Industry Generalist, focused on telecommunications technology, at the Gartner Group, where he was also Executive Assistant to the CEO, Gideon Gartner. He began his career in 1983 in Austin, Texas at Business Development Partners, an early stage venture capital partnership. Jack holds a BA in Economics from the University of Virginia. Jack currently serves on the boards of Vision Chain, CorasWorks, Triumfant, eMinor and Digital Sports. Past board or observer seats include SafeView, Inc. (acquired by L3 Communications), Matrics (acquired by Symbol Technologies), Giga Information Group (Nasdaq: GIGX. Lead Director), acquired by Forrester, Telogy Networks, (acquired by Texas Instruments), Tantivy (acquired by Interdigital), AnswerLogic (acquired by Primus Knowledge Systems), and Blackboard, Inc. (Nasdaq: BBBB). He is a Director of the Computer & Communications Industry Association, and is a member of the Naval Research Advisory Counsel for the Office of Naval Research. Jack has previously served three years as co-chair of MAVA's Capital Connection Selection Committee. He is on the Investment Committee of the New Markets Growth Fund, an SBA leveraged fund associated with the University of Maryland targeting development oriented private equity investments in disadvantaged areas. He is a frequent speaker on entrepreneurship for the U.S. Department of Commerce, and has made presentations for them in Russia, China and Japan. Jack is on the Business Advisory Council for the Montgomery County Council. Jack is a Vice Chairman on the Board of the Baltimore Symphony Orchestra and also serves on their Finance and Executive Committees.
_______________________
John Brasch
( University of Nebraska - Lincoln )
Talking Points
Towards understanding the personality characteristics of successful entrepreneurs. Is it the inventor? Or the serial startup specialist who has been defined by: "Do it my way"; "Passionate"; "Wants to do it all" ; or is it the developer who delegates and gets out of the way?
Bio
John began his working life in Lincoln as a professor in the College of Business Administration at the University of Nebraska from 1969 to 1980. While at UNL he founded International Management Services, Inc. (IMSI). With a dozen employees IMSI was as an independent export distributor for several Nebraska corporations, operating in more than 15 countries. In time IMSI evolved into Senior Technologies, Inc. (STI) with over 200 employees. STI operated as a full function original equipment manufacturer (OEM). It was the leading brand marketer of electronic safety products used in institutional care of the elderly. After selling the company to the Stanley Works, an S&P 500 company, in 2002, John continued as CEO of Stanley Senior Technologies. M&A was a significant part of his responsibility while with Stanley. John is the board president of Family Service Lincoln, a member of the Lincoln Partnership for Economic Development. He is married to Beatty, has two children and two very young grandsons.
_______________________
Larry Brown
( Co-founder, Sensics Inc. )
Talking Points
I will discuss my experiences in starting Sensics: how the key technology originated, the path to securing rights to the technology, types of funding secured and future plans.
Bio
Larry left the Johns Hopkins Wilmer Eye Institute with his co-founder in 2003 to start Sensics. Sensics spent its first three years making a production version of the original technology, raising approximately $1M through R&D contracts and angel investment. The company has now booked approximately $1.2M in product revenue since launching the first product just over one year ago. Sensics is growing, but currently has five employees and many well-known customers in North America, Europe, Australia and Asia. Larry earned a Ph.D. from the Johns Hopkins University in 1997, where he specialized in vision science. Dr. Brown has also completed a post-doctoral fellowship at the Wilmer Eye Institute, served on the board of the Baltimore Chapter of the Project Management Institute, and participated in the MindShare program. MindShare is an invitation-only program that selects the most promising high-tech business leaders in the greater DC area and provides coaching and mentoring on start-up success. Larry has also worked as project manager and a programmer, writing code for biological neural networks, particle physics experiments, credit score processing applications and web applications.
_______________________
Mark Burns
( Vesbridge Partners )
Talking Points
I will talk about working with our portfolio companies (including university start ups) on moving from the start up phase to an established company through the creation of an infrastructure designed for growth, building effective management teams and accelerating the business development process.
Bio
Mark joined Vesbridge in 2004 from St. Paul Venture Capital (SPVC) (our predecessor firm) and if focused on investments in information technology. He manages the firm’s resource network, leads the firm’s management team building initiatives and is responsible for the firm’s efforts in accelerating business development on behalf of our portfolio companies. Prior to SPVC, Mark was a manager in the consulting practice of Vitale, Caturano & Co., a full service CPA and consulting firm. Prior to Vitale, Mark spent 10 years at Arthur Andersen in the Boston office.
_______________________
Melissa Carrier
( Director of Venture Investments, University of Maryland, Dingman Center for Entrepreneurship )
Talking Points
Angel investors are a critical component of economic development and business creation in the United States. With total investments of $25.6B last year, angels continue to rival Venture Capitalists. Additionally, angel investors are continuing to be sophisticated in the way they approach the market, self-organize, and negotiate deals. At the University of Maryland, our Capital Access Network program provides open and efficient access to early-stage angel capital for entrepreneurs in the DC Metro area. Additionally, our University of Maryland Alumni E-Fund invests in student, faculty, and alumni-run businesses, where returns are directly reinvested in our programs.
Bio
Melissa Carrier joined the Dingman Center in 2006 after 11 years of leading organizational growth for technology companies ranging from Fortune 500 to early stage start-ups. Ms. Carrier brings broad experience across corporate and product-line positions including acquisitions and divestitures, venture investments, partnerships, new product launches, system implementations and marketing programs. Melissa previously served as Finance Director for AT&T Mergers and Acquisitions. While at AT&T, she also led investments for the company's Strategic Venture fund. In this role, Melissa had lead responsibility for managing the investment pipeline, analyzing financial and market data, performing on-site due diligence, and executing deals. During her tenure at AT&T, she also served as the Product Manager for the MVNO wireless data content offering/platform as well as Manager of Strategy and Business Development for AT&T Consumer Services. Ms. Carrier began her career as a process consultant for Andersen Consulting. During this time, she worked with U.S. and European clients on business process design and ERP system implementations. Subsequently, Ms. Carrier served as a Director at two startup technology companies focused on web-based business-to-business strategies. Immediately prior to obtaining her MBA, Melissa led strategic development of core processes for SAP's Global Solution Center. Ms. Carrier received a BS in Chemical Engineering from The Ohio State University and an MBA with Honors in Finance and Strategic Management from The Wharton School of The University of Pennsylvania.
_______________________
Dean Chang
( Director, Technology Ventures, University of Maryland )
Talking Points
I will talk about the anatomy of a Great Biz Plan Competition and Which Biz Plan Competitions Really Work And Why.
Bio
Dean oversees all the MTECH Ventures and Education programs, including: the TAP venture incubator, VentureAccelerator, the University of Maryland Technology Start-Up Boot Camp, the University of Maryland $50K Business Plan Competition, the Hinman CEOs Program, and other educational entrepreneurship offerings at the University. Dean previously held the dual roles of Chief Technology Officer and Vice President of Gaming Business at Immersion Corporation, a company he helped guide over ten years from a four-person, venture-backed, Silicon Valley startup to a $200M publicly traded technology leader (NASDAQ: IMMR). As general manager, Dean was responsible for strategic direction, sales and marketing, and operations of licensing Immersion's vast patent portfolio to the video game industry. Dean has written articles for Computer Magazine, BusinessWeek Online, and GameDAILY BIZ, and has been a speaker at executive, leadership, and press technology forums. He holds 30 U.S. and international patents in the field of haptics. Dean was a Pi Tau Sigma graduate from MIT; he holds a B.S. in mechanical engineering from MIT, as well as both an M.S. and Ph.D. in mechanical engineering from Stanford University. He also holds an MBA with honors, and received the highest distinction of Palmer Scholar from the Wharton School of the University of Pennsylvania.
_______________________
Matthew Christensen
( University of Wisconsin-Madison )
Talking Points
I plan to give a "users" view of various regional programs for university start-ups in the Mid-West. I will elaborate on what resources have proven helpful for entrepreneurs at universities in the region.
Bio
Matthew Christensen is currently a graduate student in medical physics at the University of Wisconsin-Madison working towards his PhD. Matt has taken advantage of several opportunities for aspiring entrepreneurs in the Mid-West region, including participating in the G. Steven Burrill business plan competition at UW, winning first prize in the MIT Enterprise Forum of Chicago Whiteboard competition, competing in the Midwest Emerging Companies Showcase and completing the first ever Wisconsin Entrepreneurial Bootcamp at UW. Matt has co-founded Medical Imaging Sciences, which plans to commercialize technology for GI disorders and is currently in the process of patenting through WARF. He also holds a BS in biomedical engineering from Boston University.
_______________________
Tom Churchwell
( Managing Partner, ARCH Development Partners )
Talking Points
I will speak to our experience in seed funding university spin outs in the Midwest which has been our focus for a number of years.
Bio
Thomas L. Churchwell is Managing Partner of ARCH Development Partners L.L.C., a very-early stage venture partnership which specializes in the creation and funding of high-tech companies in the Midwest. Previously, he was President and CEO of ARCH Development Corporation, a subsidiary of the University of Chicago, which commercialized technology from the University and Argonne National Laboratory. Prior to that, he was President and CEO of Calgene Fresh, Inc., a 1992 start-up company which produced and marketed the MacGregor’s FLAVR SAVR tomato, the world’s first biotech food product. Prior to joining Calgene Fresh, Mr. Churchwell was Vice President of ARCH Development Corporation Development. Before starting Calgene Fresh, Mr. Churchwell held several senior management positions at the NutraSweet Company, including Vice President, Sales and legal positions at G.D. Searle & Co., American Hospital Supply Corporation and The Coca-Cola Export Corporation. Mr. Churchwell is a director of TiE Midwest, Chicagoland Entrepreneurial Center, iBio, the Illinois Venture Capital Association, and number of start-up companies in the Chicago area. He holds a BA degree from DePauw University and JD degree from Northwestern University School of Law. He also is a Graduate of the Advanced Management Program at Harvard Graduate School of Business Administration.
_______________________
Edward Clancy
( National Science Foundation )
_______________________
Don Clark
( General Manager, NEC Corporation of America )
Talking Points
I will discuss technology transfer and business development from a corporate perspective. As one of the largest commercial research organizations in the world, NEC faces many of the same challenges as universities do in turning innovations into business success. I will share our experiences spinning in new business from our research organizations, spinning out new venture back businesses, and licensing technology.
Bio
Don Clark is General Manager of Corporate Planning for NEC Corporation of America. He leads the Strategy, Venture Relations, Corporate Development and Licensing activities for NEC in the United States. Don has led licensing transactions in diverse areas as video analysis, performance analysis software and nanotechnology. Don received his BA from UC Davis and is a Chartered Financial Analyst.
_______________________
Michael Cleare
( Associate Vice Provost for Research and Executive Director Technology Transfer, University of Pennsylvania )
Bio
Dr. Cleare worked for 30 years at Johnson Matthey, a UK based multinational world leader in advanced materials technology prior to joining Columbia/STV in August 2000. His experiences range from the Senior R&D Executive through Business Development to a range of senior business management positions, and included serving on the main Board of the Company for four years. While in R&D he was involved in the discovery and development of a major new class of anti-cancer drugs (platinum based - particularly carboplatin). He served as President of several of the company’s major divisions, including Pharmaceutical Materials, Chemicals and Metals, Catalytic Systems and Electronic Materials. He has managed complex global businesses, negotiated and closed multi-million dollar licensing and technology transfer deals, and entered into multiple research funding agreements with major universities. From 2000-7 Dr Cleare was the Executive Director of Science and Technology Ventures at Columbia University in New York. This position included responsibility for all Technology Transfer activities at Columbia and involved licensing, spin off/Start up companies , Industrial Research funding and Domestic and International partnerships relating to IP. He reported to the Senior Executive Vice President. In August 2007 he joined the University of Pennsylvania as Associate Vice Provost for Research, responsible for all Technology transfer, IP management and industrial liaison activities. For nine years, Dr. Cleare was a member of the board of directors of the Canadian biotechnology company, AnorMed.
_______________________
Ronald Cooper
( Senior Policy Analyst, U.S. Small Business Administration )
Bio
Ronald Cooper is Senior Policy Analyst of the U.S. Small Business Administration’s Office of Technology. He conducts economic and policy analysis on issues related to technology innovation and small business, and provides management and oversight of several federal innovation programs including the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, and until recent years, the Federal and State Technology Partnership (FAST) program. In this position, Dr. Cooper works on a range of innovation policy issues with the Administration, Congress, state governments and organizations, NGOs that provide business assistance or regional development services, individual small businesses, and industry groups including venture capital and small business associations. Dr. Cooper holds a Ph.D. in Economics; has published articles and books in the areas of technological innovation, economic policy, and economic development; and has lectured on these topics in the United States, Europe and Latin America.
_______________________
Paul Cummings
( Principal, Honda Strategic Venturing )
Talking Points
I will talk about early stage investment from a corporate/strategic viewpoint. In this context, I will discuss how early stage companies can benefit from joint development activities with a corporate investor to evolve early stage technologies to commercial products.
Bio
Paul Cummings is a Principal of Honda Strategic Venturing (HSV), the corporate venture capital arm of Honda Motor Corporation based in Mountain View, California. HSV seeks investment opportunities in technology venture companies to establish the strategic foundation for collaborative partnership both to excel Honda’s innovative R&D and to help technology venture companies succeed in Honda’s product markets. Prior to joining Honda, Paul held various management positions with automotive tier 1 supplier Delphi; including, positions in mergers and acquisitions, business development and operations for a Japanese partnered joint venture. Paul also worked for Accenture in the Sydney, Australia office with the Strategy Consulting Practice. Paul holds an MBA from the University of Chicago, and BA from Michigan State University.
_______________________
Brian Cummings
( Executive Director, Technology Commercialization, University of Utah )
Talking Points
There has been much debate about the creation of technology ecosystems built around Universities for the benefit of regional economic development. There are clear cut examples of this success at some of the major research institutions around the country; but is this a model that can or should be replicated by smaller universities nationwide? Too often the masses attempt to replicate the few and fail. By ripping up the traditional hierarchy at US research universities we are hoping to create a new service based model for commercialization that aligns State and Venture stakeholders and focuses efforts toward a business development approach in translating research into opportunities. You decide if it can be repeated in your region.
Bio
Brian Cummings is currently the Executive Director of the Technology Commercialization Office at the University of Utah. In the two years that he has been in this role the office has produced record revenues and successfully started 37 new technology-based companies, 80% of which have received initial funding and beyond. Brian has started three companies in his entrepreneurial career and is currently President of a University-based personalized medicine company. Previously, Brian led the life science commercialization efforts at the University of Texas and prior to that was the Director of Business Development at Micro-Bac International. Brian currently serves on the Board for The Utah Life Science Association, The Rocky Mountain Research Center for Emerging Infectious Diseases, The Governor’s Board for Business Resource Centers, The Renaissance Foundation and the LES Board for Technology Commercialization Structure and Development.
_______________________
Brian Darmody
( Associate Vice President, University of Maryland )
Talking Points
University business plan competitions increasingly are being integrated into university and regional technology-based economic development efforts. I will open the panel by briefly discussing the history of business plan competitions, linking them to the university start ups, comment on emerging trends in these competitions, and lead a discussion among the panelists on best practices, regionally and nationally. Discussion of panelists will summarize their programs, leading to discussion concerning ways business plan competitions can align themselves with start up creation, entrepreneurial education and start up experience. University Business Plan Competitions: The New Look.
Bio
Brian Darmody is Associate Vice President for Research and Economic Development at the University of Maryland. He has been involved with launching the University's Office of Technology Commercialization, the Maryland Technology Development Corporation (TEDCO), Research Parks Maryland (RPM) and other technology development entities. Previously he worked as University General Counsel, Director of University Government Relations, and at US Health Care Financing Administration, US House of Representatives and Maryland General Assembly. For 2007-08 he chairs the University Network of Entrepreneurs (UM NET).
_______________________
Vinse Davidson
( Partner and Chief Financial Officer, STARTech )
Talking Points
Role of Collaboration in University Commercialization Spinout Entities. Although it is very hard to commercialize research, collaboration of the University’s researchers, departments and transfer professionals with the business managers, government and investors interested in commercialization can reduce the risks and improve returns. It is important to understand and address the different needs of the parties in evolving a promising technology into a successful enterprise and a model emphasizing the value of collaborative efforts will be discussed.
Bio
Vinse Davidson serves as the Chief Financial Officer for STARTech with responsibility for the finance, accounting, reporting and facilities functions. He has over 20 years of business experience, with significant roles in the financial and operational aspects of real estate, computer systems management, and infrastructure construction. Before joining STARTech, he assisted start-up stage companies as an interim CFO. His career includes work for MasTec, Inc., a national construction company, as Division President and at Trammell Crow Company as CFO of their Dallas Industrial Division. He has also provided independent consulting services that included supporting business sales, operational systems analysis and training. Vinse began his career in the Dallas office of what is now Ernst & Young. He holds a Bachelor's degree in business from the University of Tennessee at Martin and a Master of Professional Accounting degree from The University of Texas at Austin. He is a licensed CPA.
_______________________
David Day
( Director, University of Florida )
Talking Points
Mr. Day will outline how to organize angel funds from the perspective of a niversity technology transfer office. He will also brief the audience on the value and techniques of working with a univeristy's benevolent foundation. Finally, he will detail legislative initiatives in the star of Florida to support new start-up creation.
Bio
David L. Day joined the Office of Technology Licensing at the University of Florida as Director on April 2, 2001, where he oversees the commercialization efforts of all UF technologies. Mr. Day also serves as Director of the Sid Martin Biotechnology Incubator in Alachua, FL, since 2003. Mr. Day serves on the Board of Directors of BioFlorida, the McKnight Brain Institute Advisory Panel, the Board of Directors Executive Committee of the Florida Research Consortium, and the board of Directors Executive Committee of the Southeastern Bio Investors Forum. From 1995 to 2001, he served as the Director of the UAB Research Foundation at the University of Alabama at Birmingham. David received a Master of Business Administration from the University of Alabama in 1987 and has a Masters of Library and Information Studies from the University of Alabama, 1977.
_______________________
Robert Diamond
( Manager, Marketing and Business Development, Montgomery County, Dept of Economic Development )
Talking Points
Where did the technology originate? How did you and your organization secure it? How did you fund the initial acquisition of the technology and start-up of your business? What were the steps you took to move your product along in development? When did you commercialize your first product? What steps did you take to move from R&D to commercialization? What follow-on funding did you acquire and how? Where is your technology now? Is it revenue producing? What are your plans for the future of your current technology or the acquisition of others? What lessons have you learned and would you do it differently if you could?
Bio
Bob Diamond began his professional career as an MIS programmer with IBM’s Federal Systems Division in Owego, NY. Bob advanced through a number of technical and management positions with IBM divisions in Gaithersburg and Bethesda, Maryland and Boca Raton, Florida. Returning to Maryland in 1994, Bob joined Manugistics Inc. Bob held a number of senior management positions within the company, including Vice President, Corporate Services, where he had responsibility for the company’s global Information Technology, Security and Real Estate organizations. In 2001, the Manugistics’ IT organization was named to Computerworld’s list of 100 Best Places to work in IT. In January 2006, Bob received a special appointment to become Assistant Secretary for Business Development, Department of Business and Economic Development, for the State of Maryland, where he led a team responsible for attracting and nurturing businesses into and in the State. In January 2007, Bob was appointed to the Montgomery County, Maryland Department of Economic Development, where is the Director of the Marketing and Business Development division. Bob has served on the Board of Directors of the Technology Council of Maryland and Norbeck Country Club. He chairs the President’s Advisory Council on Business Outreach for the University of Maryland, Baltimore County (UMBC), where he is also a part-time Information Systems Department instructor. Bob is a charter member of the CIO Roundtable of Montgomery County. Bob is a graduate of the state University of New York at Binghamton. He lives in Derwood, Maryland with his wife. His daughter is a public school teacher in Mount Airy, Maryland, and his son is student at Penn State.
_______________________
Allen Dines
( Assistant Director, UW-Madison Office of Corporate Relations )
Talking Points
Universities are exploring a wide variety of novel ways to increase the number and quality of startup ventures based on the research accomplishments of their faculties. The Midwest Research University Network (MRUN) was formed in the belief that through regional cooperation, these objectives could be further enhanced and regional benefits would accrue to individual universities in the network. How are universities actually fostering growth of their startups through regional cooperative efforts? This panel and my talk will provide examples of several MRUN initiatives that are producing favorable results.
Bio
Mr. Dines is Assistant Director of the University of Wisconsin-Madison Office of Corporate Relations (OCR). Operating within the Office of the Chancellor, the Corporate Relations office assists the business community in accessing the diverse resources of the University of Wisconsin-Madison (UW-Madison). As Assistant Director, he serves as Program Manager for OCR’s entrepreneurship programs including its Startup Initiative and the UW-Madison Kauffman Campus-wide Entrepreneurship program. Mr. Dines joined the UW-Madison in 2001 bringing with him more than 25 years of experience in industry and technology management. He founded, grew and sold two biotech startups and in his initial position at the university he served as Assistant Director for Business Development, within the Graduate School where his major focus was commercialization of university technology through startup business development. In 2002, Mr. Dines co-founded the Midwest Research University Network (MRUN), an alliance of Midwest research institutions dedicated to regional cooperation in the commercialization of university research through new business creation.
_______________________
Mark M. Ellison
( Director, Emerging Technology Program, Office of the Governor, Texas )
Talking Points
A new day in TEXAS! - Shifting from Technology Transfer to Technology Commercialization within Texas Universities.
Bio
Mark M. Ellison is the Director of the Emerging Technology Program for the Office of the Governor Economic Development and Tourism. His extensive experience in the private and public sector complement his leadership of initiatives that establish strong ties with industry and ensure strong business involvement. Before joining the Governors Office Mark M. Ellison held the position as Director of the Office of Employer Initiatives for the Texas Workforce Commission. Before joining TWC Mr. Ellison was a partner in a specialty investment banking firm in Dallas. As Assistant Commissioner of Marketing and Agribusiness Development for the Texas Department of Agriculture (TDA) for then, Commissioner Rick Perry, he led domestic and international marketing and economic development efforts for the Texas Department of Agriculture. Mr. Ellison has also served as international trade specialist for U.S. Wheat Associates in Washington D.C. and Casablanca, Morocco, then continued in Casablanca as a marketing specialist. Returning to Washington, D.C. as an international trade policy consultant, his clients included the retailing, consumer electronics and agricultural commodity industries. Mr. Ellison is a member of the Texas Economic Development Council (TEDC) and the International Economic Development Council (IEDC). He earned a bachelor of Science degree cumlaude in Agriculture from Texas A&M University.
_______________________
Steve Ferguson
( Director, National Institutes of Health )
Talking Points
As a healthcare agency and a major sponsor of university research, NIH is also interested in accelerating the pace of how such research results reach the public. University-based biomedical start-ups should not overlook the benefits of interacting with the NIH and other federal labs, not the least because of non-dilutive funding, technical assistance, opportunities for collaboration, new technology sourcing or even as new customer.
Bio
Steven M. Ferguson currently serves in the NIH Office of Technology Transfer as the Director of the Division of Technology Development and Transfer, the patent & licensing group for NIH and FDA technologies. Prior to joining NIH Office of Technology Transfer in 1990, Mr. Ferguson served in marketing and management positions in biomedical firms subsequent to being a scientist at the National Cancer Institute. His healthcare experience has also included work as Director of Marketing and Public Relations for a rural 70-bed hospital. Registered to practice before the USPTO, Mr. Ferguson also holds Master's Degrees in Business Administration (George Washington University) and Chemistry (University of Cincinnati) as well as Bachelor’s Degree in Chemistry (Case Western Reserve University). Mr. Ferguson has been an economic reviewer for Maryland Industrial Partnerships (MIPS) as well as the Advanced Technology Program (ATP) grant programs and is an instructor for both the USDA Graduate School and the NIH FAES Graduate School where he also the department chair for the new Certificate in Technology Transfer Program. Mr. Ferguson was also the Susan T. and Charles E. Harris Visiting Lecturer at the Watson School of Biological Sciences at the Cold Spring Harbor Laboratory and has published articles on licensing and technology transfer issues in such publications as Journal of Biolaw and Business, Journal of Pharmaceutical Development & Regulation, Drug Discovery Today, Personalized Medicine, Nature Biotechnology, AUTM Journal and Current Drug Discovery Technology. He is also the co-author of Starting & Operating A Business in the District of Columbia and Starting & Operating A Business in West Virginia. He has received the NIH Director’s Award and six NIH Merit Awards in recognition of his activities in the management and negotiation of technology licensing agreements for the National Institutes of Health.
_______________________
Mark Frantz
( RedShift Ventures )
Talking Points
I will talk about that technology transfer from universities, either start-ups or licensing opportunities, helps drive innovation in our country and across the globe. While good work has been done to date, the more we can do to further encourage the activities, the more likely we are to have a vibrant, robust economy for decades to come.
Bio
Mark is focused on software and media investments for RedShift Ventures and currently serves on the Board of Directors at portfolio companies Intelliworks and TerraGo Technologies. Mr. Frantz also serves on the Board of Directors at ODIN Technologies, the Northern Virginia Technology Council (NVTC) and the Commonwealth of Virginia's Research & Technology Advisory Council (VRTAC). Mark has also been an investor/advisor to New Media Strategies (acq. by Meredith Corp., NYSE - "MDP"), Sourcefire (Nasdaq - "FIRE"), Luna Innovations (Nasdaq - "LUNA") and American Teleradiology Nighthawks (acq. by Nighthawk Radiology Services, Nasdaq - "NHWK"). Mr. Frantz was previously the Managing General Partner of In-Q-Tel, the strategic venture capital affiliate of the U.S. Intelligence Community. Prior to that, Mark was with Carlyle Venture Partners, where he worked with Blackboard (Nasdaq - "BBBB"), Imagitas (acq. by Pitney Bowes, NYSE -"PBI"), ISR Solutions (acq. by Stanley Works, NYSE - "SWK"), Panasas, Grant Street Group and Secure Elements. Mr. Frantz joined Carlyle from Redleaf Ventures, where he worked with various portfolio companies including Lightningcast (acq. by AOL/TimeWarner, NYSE - "TWX"). Prior to Redleaf, he was the Associate to the Senior Chairman of Alex. Brown and he worked extensively with the Technology and Internet groups. Mark has also served as the Associate Director of The White House Office of Intergovernmental Affairs under President George H. W. Bush and as the economic and technology policy advisor to Pennsylvania Governor Tom Ridge, where he came up with idea for the early-stage venture capital fund that is now known as PA Early Stage Partners. Mr. Frantz is actively involved in the community, having served as the Co-Chair of the Greater Washington Board of Trade Technology Transfer Task Force, a member of the Advisory Committee on Technology Transfer to the Virginia Joint Commission on Technology & Science, Accelerating Innovation/Tech Transfer 2005, the 2002 & 2003 "Technology Transfer in the Mid-Atlantic" Steering Committee, the Chairman of the Northern Virginia Technology Council's Private Equity Committee, Co-Chair of the Program Committee for the Mid-Atlantic Venture Association ("MAVA"). Mark holds J.D. and M.B.A. degrees from the University of Pittsburgh and a B.A. degree from Allegheny College. Mr. Frantz was an NCAA All-American swimmer at Allegheny and has qualified for the USA Triathlon National Championship eight times.
_______________________
John Fraser
( Past President, AUTM; Assistant Vice President for Research and Economic Development, and Executive Director of the Office of IP Development & Commercialization, Florida State University )
Talking Points
US academic technology transfer is an enormous enterprise, engaging two hundred research universities and thousands of companies. This presentation will provide details of the scope and magnitude of the enterprise as well as examples of the success of the activity over a number of years in terms of companies started and products introduced into the marketplace to save lives, enhance the quality of life of patients and to increase the productivity and global competitiveness. A 1999 AUTM study showed that this activity has helped the private sector create over $ 32 billion in annual sales and an additional $ 8 billion in induced product development and supported 280,000 jobs.
Bio
Mr. Fraser is currently Assistant Vice President for Research and Economic Development, and Executive Director of the Office of IP Development & Commercialization, Florida State University, Tallahassee, Florida (1996-present). Prior to that he served as Director, University/Industry Liaison Office at Simon Fraser University, Vancouver, Canada. Mr. Fraser brings substantial corporate and university experience to the FSU position. He has held positions as Executive Vice President and co-founder of UTC, Inc., a venture capital backed, North Carolina-based university licensing/technology transfer firm; President and CEO of UTI, a University of Calgary based for-profit technology transfer company; Vice President of TDC, Inc., a Toronto and Vancouver-based venture capital firm and President, Burnside Development, a technology commercialization consulting firm. He has co-founded three companies and assisted entrepreneurs launch another twelve technology based firms. He is a member of the Board of Trustees of the technology transfer association AUTM, and served as its 2006 President. He is a Founding Board Director of the Tallahassee region technology association, the TalTech Alliance and its Executive Committee; is a Founding member of Board of the Florida Research Consortium and its Executive Committee, appointed by the Governor to increase university/company interactions to better the Florida economy; is a Member of the Board of BioFlorida, the statewide bio/life sciences trade association. Mr. Fraser holds a Masters Degree in Biochemistry from the University of California - Berkeley.
_______________________
Venky Ganesan
( Managing Director, Globespan Capital Partners )
Talking Points
VC's are from Mars and Entrepreneurs are from Venus. With my apologies to pop psychology, I will try to help explain how VC's are similar and different to entrepreneurs and how you can use that knowledge to better market yourself and eventually get funded by a VC. If you always wanted to understand how VC's think, why they ask the questions they do, and what they actually want to know - this is your talk.
Bio
Venky focuses on enterprise software and infrastructure investments. In addition to Palo Alto Networks, he is actively involved with Agitar, Amobee, Exeros, Jajah, Marketlive, Nominum, oDesk, Plaxo, and Strongmail. Prior to Globespan, Venky was the co-founder and Chief Operating Officer of Trigo Technologies, Inc. which was acquired by IBM in 2004. Previously, Venky worked with McKinsey & Co. in their Los Angeles and Johannesberg offices. He also was a program manager at Microsoft's Encarta group. Venky received degrees in Computer Science, Math, and Economics from both the California Institute of Technology and Reed College.
_______________________
Julie Gerstenberger
( Director, External Alliances, Eastman Kodak Company )
Talking Points
Representing the perspective of a strategic venture investor and potential customer/supplier for university start-ups, I will discuss how Kodak uses key university research partnerships to engage with the university startup ecosystem and to support mutually beneficial strategic alliances. I will also touch on how university licensing policies may promote or inhibit the growth of those startups.
Bio
Julie Gerstenberger is a Director, External Alliances at Eastman Kodak Company. Kodak External Alliances strengthens Kodak’s competitive position by seeking out and leveraging targeted strategic innovation, technology and intellectual property through alliances with universities, government laboratories and early-stage firms. Ms. Gerstenberger works with the Consumer Digital Group and Kodak Research Laboratories to create strategic partnerships that complement Kodak’s core competencies in Consumer Imaging, primarily through university research sponsorship and venture alliances/investments. Her current investment focus is on consumer imaging systems and services, including applications/devices, infrastructure and enabling technologies for consumer markets. Particular areas of interest include distributed media services and intelligent systems. Ms. Gerstenberger brings operational experience in the development and commercialization of digital imaging systems for a wide range of applications and markets, including some of Kodak’s earliest digital imaging systems. She holds an M.S. in Optics from the University of Rochester and a B.S. in Electrical Engineering from the University of Michigan.
_______________________
Shomit Ghose
( Partner, ONSET Ventures )
Talking Points
I will talk about how investors can begin an engagement with a university – surveying the field of opportunities, building relationships, and cultivating/developing promising ideas – based on my own experience in having funded multiple university-based startups. I will also talk about how universities can make it easier for investors to engage with them.
Bio
Shomit Ghose is a Venture Partner at ONSET Ventures, having joined the firm in 2001 after 19 years of working at high-tech companies in the Silicon Valley. During his operating career he worked at several successful start-ups, including Sun Microsystems, BroadVision, and Tumbleweed Communications. At ONSET, Shomit has worked closely in operational roles with portfolio companies in the software and networking sectors, and was also responsible for ONSET’s investments in Truviso, Ilial and Moteiv. Shomit is an Industry Fellow at the University of California, Berkeley, and has been active with entrepreneurial activities with a number of California universities. Shomit was awarded two academic scholarships to UC-Berkeley at age 15 and graduated in 1982 with a degree in Computer Science.
_______________________
Lawrence Gilbert
( Senior Director of Technology Transfer, Caltech )
Talking Points
The importance of an entrepreneurial culture in the creation of university start-ups. That plus critical mass are requisites for success in fostering start-ups.
Bio
Lawrence Gilbert is the Senior Director of Technology Transfer, of Caltech, the California Institute of Technology. The Office of Technology Transfer (OTT) provides a service to Caltech faculty members, other Caltech researchers, and Jet Propulsion Laboratory (JPL) technologists by protecting the intellectual property developed in their Caltech and JPL labs. The OTT fosters the commercial development of Caltech technologies in companies ranging from local start-ups to large, multi-national firms. Mr. Gilbert has been involved in the formation of more than 80 start-ups based upon or associated with university research. Several have gone public or have been acquired, and many have products in the marketplace. He acts primarily as a catalyst in putting the deal together, linking faculty, technology, and venture capital. Mr. Gilbert was formerly the Director of Patent Licensing for Massachusetts Institute of Technology (MIT). Prior experience includes Patent Consultant to various universities, including Boston University, Brandeis, Tufts, and the University of Massachusetts Medical Center and as the Director of Patent and Technology Administration of Boston University. Mr. Gilbert is a member of the Licensing Executive Society (LES) and a former Chairman of its Committee on Technology Transfer; and is a Founder of the former Society of University Patent Administrators, now known as the Association of University Technology Managers (AUTM). He is a member of the Executive Committee of the MIT/Caltech Enterprise Forum and formerly a member of the Board of Directors of the Southern California Biomedical Council and a former member of the Advisory Committee of the Business Technology Center, a high-tech incubator sponsored by the Los Angeles County Community Development Commission. Mr. Gilbert received his B.A. from Brandeis University; an MBA degree from the American Graduate School of International Management (Thunderbird); and a J.D. from Suffolk University; he is registered to practice before the U.S. Patent and Trademark Office (USPTO). Mr. Gilbert has been a frequent lecturer on patent and licensing matters and written several articles in the field.
_______________________
James Golubieski
( President, Foundation Venture Capital Group, LLC )
Talking Points
Foundation Venture Capital Group, an affiliate of New Jersey Health Foundation, was established to invest exclusively in technology coming out of the University of Medicine & Dentistry of New Jersey. What makes us unique is that, at this point, we are unaware of any other independent foundation that has created its own venture capital fund to invest pre-seed funding exclusively in a specific university’s start-up groups. During our session I will discuss the unique structure of our organization; why we established it; how we work with the Office of Patents and Licensing at the University and our due diligence process. I’ll also talk about the first organization in which we invested and those close to closing at this time.
Bio
James M. Golubieski is President of the Foundation Venture Capital Group, LLC, and the New Jersey Health Foundation. Both organizations support the growth of the University of Medicine and Dentistry of New Jersey. Mr. Golubieski had been CFO of Array Medical, Inc., a medical device company established in 1995 that developed a groundbreaking blood test to test platelet function. The company was sold in 1999. Previously, he was chief operating officer and senior executive vice president of Glendale National Bank and a member of its board of directors, president of Glendale Investment Corp. and Glendale Mortgage Services, Inc. and chief financial officer of Glendale Bancorp, which was acquired by Mellon Financial. For 10 years prior he had been with KPMG. He is a member of the New Jersey Society of Certified Public Accountants and the American Institute of Certified Public Accountants.
_______________________
Jo Anne Goodnight
( Acting Director, Division of Special Programs, Office of Extramural Programs, National Institutes of Health - NIH )
Talking Points
The NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are the best VC deal in town --a $650 million early-stage fund with no strings attached. This session will provide an overview of the NIH SBIR/STTR programs, including ways industry and academia can develop mutually beneficial partnerships for investigators seeking to commercialize their technology innovations. This session will provide an overview of the SBIR/STTR programs and will describe how entrepreneurial researchers can tap into this funding opportunity.
Bio
Ms. Goodnight currently holds the position as the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program Coordinator of the National Institutes of Health (NIH) and the Department of Health and Human Services (DHHS) Public Health Service. She is also serving as the Acting Director for the Division of Special Programs in the Office of Extramural Research (OER). Prior to joining OER in 1999, she served in positions encompassing research, program administration and program management. During her 25 years of Government service she has held positions in the U.S. Department of Agriculture (USDA), the Food and Drug Administration, and now the NIH. As part of her Virginia Tech education (1978-1983), she spent four years conducting research as a Cooperative Education student at the USDA’s Animal Parasitology Institute. While at NIH, she has been a part of the Intramural Research Program and the Extramural Research Program. As an intramural research scientist (1989–1994) at the National Cancer Institute (NCI), she published over 20 studies about the selective involvement of Protein Kinase C in differentiation and neoplastic transformation. In 1994, she transitioned to the NCI Extramural Research Program where she served as Special Assistant to the Director, Division of Cancer Biology and Program Director for SBIR/STTR grants that supported studies in the field of cancer biology, cancer genetics, and cancer immunology. In addition, she served as the NCI’s SBIR/STTR Program Policy Coordinator. She was appointed as the NIH/DHHS SBIR/STTR Program Coordinator in 1999 where she continues today. She was intimately involved in the development and implementation of the NIH SBIR/STTR Fast-Track Program and the SBIR/STTR Phase II Competing Renewal Award. She continues to develop other programs that assist the small business community in commercialization of their technologies. Ms. Goodnight has been an invited speaker at hundreds of SBIR/STTR Conferences. She also has provided written and oral testimony at Congressional hearings related to the reauthorization of the SBIR and STTR Programs. Her contributions to the SBIR/STTR programs and passion for helping small businesses to be successful in these programs have been acknowledged through several national awards including NIH Director’s Awards, NIH Merit Awards, and the Small Business Administration Tibbetts Award. Ms. Goodnight received a Bachelor of Science degree in Microbiology from Virginia Tech in 1983.
_______________________
Dan Gordon
( Director of Research, Valhalla Partners )
Talking Points
I would like to discuss "Silicon Valley vs. Washington DC: Two Data points on bringing innovation to market". Having lived in Silicon Valley from 1982-2000 and in DC from 2001-2007 (as well as growing up here), I’m in a position to draw some comparisons which I think are kind of interesting between the two environments.
Bio
Dan Gordon has twenty-nine years’ experience in the technology industry. Dan is currently Director of Research at Valhalla Partners, a Washington, DC venture-capital firm with more than $440M under management. At Valhalla, Dan is responsible for identifying emerging technologies and technology markets and for identifying innovations in universities and government labs. Prior to joining Valhalla Partners, Dan was a Director at the PricewaterhouseCoopers Global Technology Centre, a Contributing Writer and Contributing Editor to the Technology Centre's annual Technology Forecast, and a frequent speaker at industry and general business meetings. Prior to joining PwC, Dan worked in Silicon Valley as a software technologist, manager, director, and entrepreneur at companies such as Symantec, Oracle, and Intuit. Dan has a B.A cum laude from Harvard University and an M.S. degree from New York University in Computer Science. He is a Professional Member of the ACM. Dan lives in Washington, D.C. with his wife and two children.
_______________________
Tony Grover
( Managing Director, RPM Ventures )
Talking Points
Tony will discuss different models and approaches to funding university spinouts. His remarks will include insight and background on how researchers can attract entrepreneurial managers and venture capitalists to start and fund their companies as well as explaining these individual’s roles and involvement before and after their organization receives funding.
Bio
Tony Grover is managing director of RPM Ventures, a seed and early stage venture capital firm based in Ann Arbor, Mich. During his career, Grover has worked both from the venture capital side by driving investment in a number of university spinouts, and from the entrepreneurial side, as co-founder of an Internet company. Grover has also received finance, engineering and manufacturing experience with Intel Corporation and Cummins Engine Company. Grover also serves on the board of the University of Michigan Frankel Commercialization Fund and the Michigan Universities Commercialization Initiative (MUCI) Challenge Fund. He holds a Bachelor of Science in mechanical engineering from the University of Michigan, a Master of Science in industrial engineering from Purdue University, and a Master of Business Administration from the J. L. Kellogg Graduate School of Business.
_______________________
Mark Grovic
( Founding Partner and Managing Director, University of Maryland, New Markets Fund )
Talking Points
I will describe the particular approach we took to raising and investing our $25M venture fund that is independent from, but located at, the University of Maryland. Our relationship with the entrepreneurship center, incubator and tech transfer offices at the University of Maryland, and other local Universities, has greatly contributed to our success. We also teach an award winning, highly selective class to MBA candidates, law students, and graduate life science and engineering students who serve as Associates for the Fund.
Bio
Mark is a Founding Partner and Managing Director of the New Markets Growth Fund (NMGF), a $26 million venture capital fund focused on high-growth technology companies and housed at the University of Maryland, College Park (UMCP). Mark serves or served on the Board of Directors of Lightningcast (sold to NYSE: TWX), Innovative Biosensors, and Artifact Software, and is a board observer for Biosurface Engineering Technologies, BD Metrics, and Paratek Microwave, all of which are NMGF portfolio companies. Mark is also the Venture Capitalist in Residence for the R.H. Smith School of Business at UMCP, where he is a Professor of Venture Capital and Entrepreneurship. In 2004, he received the US Association of Small Business and Entrepreneurship National Outstanding Course Award for Excellence in Entrepreneurship in Education. Mark is also a Partner in Smith Advisory and Collaborative Services, a Senior Fellow in the Executive Education Department, and teaches in the UMCP Executive MBA program. Mark currently sits on the Investment Committee for the Maryland Technology Development Corporation (TEDCO), is Co-Chair of the NASA Goddard / UMCP Technology Transfer Initiative, is on the Business Review Panel for UMCP’s Technology Advancement Program (TAP) Incubator, the Incubator Company of the Year Award Committee, UMCP Inventor of the Year Selection Committee, National Collegiate Inventors and Innovators Alliance Grants Review Committee, and the US DOC’s Minority and Business Development Associations Steering Committee for minority access to capital. He is a frequent speaker at conferences and guest lecturer, and has been a regular contributor to domestic and international publications. Mark graduated Cum Laude from the University of California, Berkeley, in 1989 where he majored in international politics and economics. In 1994 he received a Juris Doctor from the Georgetown University Law Center, where his focus was in international, tax, and corporate law. Mark has also completed graduate work in accounting and finance at the George Washington University School of Business and Public Management in Washington, DC, and at Pace University in New York City. Mark is married and has two children.
_______________________
David Gulley
( Associate Vice President for Technology and Economic Development, University of Illinois )
Talking Points
For more than five years, the University of Illinois has invested in developing and refining its practices to increase technology commercialization on its campuses in Chicago and Urbana-Champaign. It begins with the Offices of Technology Management and robust disclosure screenings and investments in patenting; to IllinoisVENTURES and its start-up practices, including seed and follow-on funding; and finally to incubation facilities and research parks adjacent to both campuses. There are new regional collaborations with other research institutions and corporate partners that leverage research strengths to connect academic-industry opportunities.
Bio
David L. Gulley, is Associate Vice President for Technology and Economic Development for the University of Illinois system. He also serves as Assistant Vice Chancellor for Research and Interim Director of the Office of Technology Management at the University of Illinois at Chicago. Since 1989, he has provided leadership in the University’s technology-based economic development activities that include academic-industry partnerships and technology commercialization. Gulley is active with Illinois’ technology community, recently serving on the Executive Committee for BIO2006 and leading BIO’s Academic-Industry Committee; BIO’s Technology Transfer Committee; and co-chair of iBIO’s 2007 Life Science Industry Expo and Marketplace (IndEx 2007). Gulley is also active with the Association for University Technology Managers (AUTM), serving on the Best Practices Task Force and as Graduate Course Chair. He holds a BA and PhD from Southern Illinois University and a Master’s graduate degree from Virginia Tech.
_______________________
Jim Gunton
( Co-founder, NJTC Venture Fund )
Talking Points
I will discuss NJTC Venture Fund's experience and perspective as early stage Venture Capitalists in evaluating multiple University-sponsored opportunities with the focus on "why" we chose to make the investments we did.
Bio
Mr. Gunton has been investing in privately-held growth technology companies for nearly 15 years. Before co-founding in 2001 the $80 million NJTC Venture Fund, Gunton was a manager at Oracle Corporation in the Silicon Valley. He represents NJTC Venture Fund at nine portfolio companies and is a Governor of the National Association of Small Business Investment Companies. Jim earned a BS from Stanford University and an MBA with distinction from Duke University.
_______________________
Robert Hacker
( Florida International University )
Talking Points
At FIU we have run business plan competitions and boot camps for four years. During this time the single biggest issue has been helping the students turn classroom theory into the practical requirements of a financeable business plan. For this reason we encourage local entrepreneurs to attend the boot camps and rely more and more on practioners to provide the boot camp content.
Bio
I am an Adjunct Professor at FIU where I teach entrepreneurship to undergraduates. I have been a business plan competition judge at FIU for three years and have offered boot camp sessions on the financial plan for two years. I manage a boutique investment bank in Miami that provides capital raising and financial consulting services to early stage and middle market companies in Florida, the Caribbean and Central America. Prior to returning to the U.S. in 1999, I ran a public company in Indonesia that grew from $40 million to $1 billion in annual revenue in seven years.
_______________________
Christopher Hayter
( Director, Economic Development Program, National Governors Association - NGA, Center for Best Practice )
Talking Points
I will be talking about the increasing attention that governors are giving to public-private partnerships, including with universities, to promote innovation, local university startups and entrepreneurship within and among states.
Bio
Chris Hayter is the Program Director for Economic Development at the National Governors Association Center for Best Practices. Chris is staff lead for the NGA Innovation America initiative, led by GovernorJanet Napolitano of Arizona, which seeks to help governors encourage entrepreneurship, improve math and science education, and better align post-secondary education with state innovation needs. Prior to this appointment, Chris served as Research Director for the National Council for Advanced Manufacturing (NACFAM), where he proposed and managed research project in technology and product development, and supply chain integration. He held similar positions with both the Council on Competitiveness and the National Academies' Board on Science,Technology, and Economic Policy. Previous experiences include resort management, bartending, and teaching English in the Czech Republic. Chris is a graduate of the U.S. Coast Guard Academy where he earned his Bachelor of Science in Industrial Engineering and Public Policy,completed an M.A. in International Science and Technology Policy from the George Washington University, and is currently a Ph.D. Candidate in Economics and Technology Policy.
_______________________
Chip Hazard
( General Partner, IDG Ventures Boston )
Talking Points
I will speak about best practices in starting a technology driven university spin out including case studies of companies that have successfully made this transition and the lessons learned from each.
Bio
Chip is a General Partner at IDG Ventures Boston whose investment interests and experience are in information technology with a focus on enterprise software. He currently represents IDG Ventures Boston on the boards of 1-800-FREE411 (Jingle Networks), Infobright, mValent, Placemark Investments, Reveal Imaging, and SupplyScape and was previously a director at Bowstreet, which was acquired by IBM. He also serves on the boards of Idiom and NewView Technologies. Before joining IDG Ventures in May 2002, Chip was a General Partner with Greylock, a leading national venture capital firm he joined in 1994. While at Greylock, Chip led or participated in numerous sucessful investments in the enterprise information technology field including Narrative Communications (acquired by @Home), iPhrase Technologies (acquired by IBM), IBA (acquired by ServiceSoft/Kana), Storage Networks (IPO), Totality (acquired by MCI) and the Vincam Group (IPO in 1996, acquired by ADP). Prior to Greylock, he was with Company Assistance Limited, an investment and consulting firm in Warsaw Poland; and Bain and Company, an international management consulting firm. Chip received a BA with honors from Stanford University and an MBA from Harvard Business School where he was a Baker Scholar and a Ford Scholar.
_______________________
Mark Heesen
( President, National Venture Capital Association )
Talking Points
The current state of the venture capital industry: what technologies and geographic regions are getting funded; what the future holds for venture capital; how corporate VCs are coming back into the process; the growth in early stage investing, and how public policy, venture capital and entrepreneurship intersect.
Bio
As President of the National Venture Capital Association, Mark Heesen is responsible for setting the strategic direction for all Association activities, including public policy efforts, research initiatives, educational programs, and member services. In this capacity, Mark works closely with the NVCA professional staff and Board of Directors to demonstrate the positive impact of venture capital investment on the United States economy. Under his direction, the NVCA has created numerous value-added sub-groups including the CFO Task Force, Strategic Communications Group, Corporate Venture Capital Group, Medical Industry Group and Human Capital forum, all of which are dedicated to supporting NVCA membership in uniquely critical areas. As a spokesperson for the venture capital industry, Mark is often called upon by the financial media, NVCA members, limited partners, and regional associations to present the overarching venture capital perspective to a wider audience. He is a frequent presenter at industry conferences, appears regularly on CNBC, and is consistently quoted in the press in stories concerning venture capital trends. Since 1991, Mark has worked on behalf of the NVCA to enact a wide range of policies that benefit the venture capital and entrepreneurial communities, including a significant capital gains differential, securities litigation reform, numerous SEC and FASB accounting issues, immigration reform, and a streamlining of the FDA and CMS approval processes, among other issues. Prior to coming to the NVCA, Mark was an aide to a former Governor of Pennsylvania and was Deputy Director for Federal Funds reporting to the Texas Legislature. Mark received a law degree with an emphasis in taxation from the Dickinson School of Law in 1984.
_______________________
Joe Hernandez
( President and CEO, Innovative BioSensors )
Talking Points
Where did the technology originate? How did you and your organization secure it? How did you fund the initial acquisition of the technology and start-up of your business? What were the steps you took to move your product along in development? When did you commercialize your first product? What steps did you take to move from R&D to commercialization? What follow-on funding did you acquire and how? Where is your technology now? Is it revenue producing? What are your plans for the future of your current technology or the acquisition of others? What lessons have you learned and would you do it differently if you could?
Bio
Mr. Hernandez obtained a Bachelor of Science degree in Neuroscience and graduate degrees in Molecular Genetics and Business Administration from The University of Florida. He has been published in several highly-respected scientific journals and presented at numerous scientific meetings. He has held senior level marketing, sales and business development positions at Digene Corporation, Affymetrix, Inc., and Merck. Mr. Hernandez has successfully launched numerous products in the pharmaceutical, research and diagnostic markets. He has in-depth knowledge of market research, competitive analysis and business development.
_______________________
G Duncan Hitchens
( Vice President, Lynntech, Inc. )
Bio
Dr. Hitchens received a B.Sc. Degree in Bacteriology (1981), and a Ph.D. Degree in Microbial Physiology (1985) from the University of Wales, after which he carried out post-doctoral research in electrochemistry at Texas A&M University. Dr. Hitchens is co-founder of Lynntech Inc. and has been its Vice President since 1991. Based in Texas, Lynntech Inc. is a leading technology development and technology commercialization company, with annual revenues of $15 million. Dr. Hitchens is co-inventor on over 20 patents, has received 5 NASA Certificates of Recognition, has co-authored over 40 scientific publications and has made numerous technical presentations. He currently oversees 40 scientists and product development engineers, emphasizing technology marketing to corporate clients and establishment of strategic partnerships. His work has led to several licenses to leading companies in the fields of consumer products, infection control and fuel cell power sources. He currently oversees early-stage technology development programs valued at over $5 million annually. Recently, he established Lynntech’s Technology Transfer Office in Richardson, Texas, with the goal of promoting collaborative activities between Lynntech Inc. and the Dallas/Fort Worth University research community.
_______________________
Richard Holdren
( Healthcare Angels )
Bio
Co-Founder of Equivision, publicly traded on NASDAQ and sold for over 70 million cash, and EquiMed a publicly traded cancer management company with a market cap over $200 million, Rick has additionally co-founded/Invested in Physician Trust (venture backed by over 5 million in investment), DaVincian Technologies (picked by Bob Ryan’s High-Tech Start-up Boot Camp), Austin Med Tech a publicly traded surgical ‘pack’ company, DermAmerica, a national cosmetic dermatology firm & MD Pain Clinics. As a serial entrepreneur Rick has founded or invested in over 26 healthcare start-ups and named as 2002 Center for Entrepreneurship & Innovation Mentor of the year. Rick also was a partner in the nation’s largest physician search firm, a director of physician relations at a major hospital management firm and co-founder of Texas’s largest practice management firm. He currently owns Appraisal & Mentor Group LLC, which is a top 3 M & A and healthcare valuation firm with over 2500+ completed assignments including over 200 court valuations. He made an investment is a ‘virtual incubator’ with ‘space-act’ agreement with NASA to commercialize its phase III SBIR companies with matching venture investment.
_______________________
Greg Horowitt
( Co-founder and Executive Director, UCSD Global CONNECT )
Bio
Greg Horowitt is the co-founder and Executive Director of Global CONNECT, based at the University of California, San Diego. He is a key thought leader in the field of ‘innovation systems’, and their relevant applications for sustainable regional economic development through technology commercialization. In addition, Greg is also the founding Managing Director of T2 Venture Capital; a seed stage venture firm focused on the commercialization of intellectual property out of leading research institutions, (academic public, and private), and government funded agency programs. Prior to founding Global CONNECT, Greg was the interim Director of the regional CONNECT program in San Diego. Greg’s background has been in executive management, where he held key positions at a Berkshire Hathaway company for nearly 20 years, served as an Entrepreneur-in-Residence at a leading Silicon Valley venture capital firm, and was the CEO of a venture-backed enterprise software company.
_______________________
Tim Howe
( Founder, CHL Medical Partners )
Talking Points
I will talk about sustaining long-term productive relationships between venture capitalists and technology transfer offices.
Bio
Tim is a founder of CHL Medical Partners, a leading healthcare venture capital group based in Stamford, CT focused on start-up and early stage investing in the biotechnology, medical device and services areas. Tim has been investing in private equity since 1984 when he joined Schroder Ventures. He has been an active investor and board member responsible for numerous venture investments in the healthcare space, including Innotech, Inc. (acquired by Johnson & Johnson), Camitro Corporation (acquired by ArQule, Inc.), and Alexion Pharmaceuticals, Inc. CHL has led the start-up of many companies directly from university settings, including CGI Pharmaceuticals, Inc., Amicus Therapeutics, Inc. (NASDAQ “FOLD”), Protometrix, Inc. (sold to Invitrogen), and BioRelix, Inc. Tim has been a director of nineteen companies and is currently on the boards of Bionaut Pharmaceuticals, Inc., Comprehensive NeuroScience, Inc., Medicus Insurance Holdings, Inc. and MedMark Services, Inc. He is also an Adjunct Assistant Professor at Columbia Graduate School of Business teaching venture capital management. Tim is a graduate of Columbia College and the Columbia Graduate School of Business. Tim can be reached at thowe@chlmedical.com.
_______________________
Eva Jack
( Associate Director of Business Development, Medimmune )
Talking Points
Where did the technology originate? How did you and your organization secure it? How did you fund the initial acquisition of the technology and start-up of your business? What were the steps you took to move your product along in development? When did you commercialize your first product? What steps did you take to move from R&D to commercialization? What follow-on funding did you acquire and how? Where is your technology now? Is it revenue producing? What are your plans for the future of your current technology or the acquisition of others? What lessons have you learned and would you do it differently if you could?
Bio
Eva M. Jack, Associate Director of Business Development, MedImmune, Inc. In her role at MedImmune, Ms. Jack is responsible for business development activities with academic and medical research institutions. Her responsibilities include identifying new and interesting research opportunities in the therapeutic areas of oncology, infectious diseases and immunological and inflammatory diseases. This includes in-licensing as well as research collaborations. Prior to MedImmune, she was at Intel Corporation for 13 years and held a variety of positions in the company. Her last job was in Intel Capital, the venture fund of the company, and was responsible for investments and research collaborations in biotechnology and health care. She was also the Technical Assistant to the Vice President of Human Resources. In this capacity, she played an integral role in the strategic planning process for the organization. Eva began her career as a lobbyist in Washington D.C. covering a variety of areas including health care, immigration, labor law and education and training. In this capacity she was responsible for developing Intel’s position on these public policy concerns. Ms. Jack holds a B.A. from the University of Virginia and a M.H.S. from Johns Hopkins University.
_______________________
Andrew Jay
( Head of Medical Solutions, Siemens Venture Capital )
Talking Points
Bio
Dr. Andrew Jay is Head of the Medical Solutions Fund at Siemens Venture Capital. Since initiating the Fund in late 2002, he has closed several investments in the medical technology and pharmaceutical arenas. Two notable IPO’s in his portfolio are Animas, a maker of external insulin pumps, and Molecular Insight Pharmaceuticals, a company developing imaging agents for cancer and cardiovascular applications. He currently is on the Board of Directors of Molecular Insight Pharmaceuticals, U-Systems, and Vasomed. He is a Board Observer at MDdatacor, and involved with Sequenom and Cylex. Dr. Jay previously was a medical technology analyst leading the practices at Wachovia Securities, Alex. Brown and Deutsche Bank Securities. Sectors under coverage included imaging, orthopedics, cardiovascular, vision, diabetes, diagnostics and neurologic devices. During his career as an Institutional Investor ranked analyst, he was commended for his stock picking acumen and industry expertise by numerous publications. He was instrumental in raising over $2 billion in equity capital for a multitude of companies and published over 10,000 pages of research and bringing over 20 medical technology companies public. He was frequently quoted and interviewed in the financial trade press including the Wall Street Journal, Investors Business Daily, CNN and MSNBC. He distinguished himself with thought-leading research on topics such as neurological devices, stroke, and the first major report on the enormous opportunity in coated stents. Prior to his time in the financial community Dr. Jay's experience includes leading healthcare consulting projects for Arthur D. Little and running his substantial dental practice. He has a Bachelor of Science from Rensselaer Polytechnic Institute, a DMD from the University of Pennsylvania and an MBA from the Kellogg School at Northwestern. Outside of the office Andrew is active in the restoration and preservation of historic Charlestown, Massachusetts where he is a Director of the Friends of City Square Park. He has also served as a Director of The Epilepsy Foundation.
_______________________
Zach Jonasson
( Seaflower Ventures )
_______________________
Greg Jones
( CEO, VisTrails, Inc., and Former State Science Advisor, Utah )
Talking Points
I will share my experiences on moving technologies from universities to the market place and on aligning state-sponsored programs with other federal and university programs that aid the entrepreneur.
Bio
Dr. Jones received his bachelor’s degree in Physics from the University of New Mexico in 1988. He also earned his doctoral degree from the University of New Mexico in Biomedical Science. Between degrees, he was an optical engineer with CVI Laser Co. in Albuquerque, New Mexico, specializing in optical testing and optical instrument design. From 1997 to 1999, he was a post-doctoral fellow at the University of Utah in the Department of Radiology where he was a member of the Functional Brain Imaging Group. He later joined Storage Technology Inc. (StorageTek) as a principal consultant in the Medical Group. In 2000, he became Associate Director of the Scientific Computing and Imaging (SCI) Institute at the University of Utah from which he co-founded university technology spin-off, Visual Influence. Visual Influence a visualization software firm was acquired in 2007. In 2005-2007 Dr. Jones served as the State Science Advisor for Utah Governor Jon Huntsman. Currently, Dr. Jones is the executive director of research for the Moran Eye Center at the University of Utah and CEO of university spin-off VisTrails, a software company founded in 2007 specializing in workflow and data provenance management tools.
_______________________
Timothy Keane
( Entrepreneur in Residence, Marquette University )
Talking Points
I will talk about the MU angel network description (80 members, two cities, deal screening and management process) and big two or three learnings over the four years we've been doing it.
Bio
Timothy J. Keane is the Entrepreneur in Residence at Marquette University in Milwaukee, Wisconsin. Prior to accepting this appointment in 2001, he was the founder and CEO of Retail Target Marketing Systems, Inc., a software company. The company was sold in 2000 and is now a unit of Metavante, a publicly traded banking services company. In his current position he manages the University based Marquette Golden Angels; teaches graduate and undergraduate courses; and is the director of the newly formed center for Cross Campus Entrepreneurship and Innovation. This new initiative was founded to bring entrepreneurial education to all of the University’s students, regardless of major field of study. His blog about advice for entrepreneurs is at www.timkeane.org. He is a director of the Angel Capital Association in Washington, DC. a director of First Business Bank, and a director of the Frank Lloyd Wright Foundation’s Preservation Society. Before founding Retail Target Marketing Systems, Inc. in 1989, he was the manager of worldwide marketing communications for GE Healthcare with offices in Frankfurt, Madrid, London and Amsterdam. He is a graduate of Seattle and Marquette Universities.
_______________________
Todd Keiller
( Director, Technology Transfer, University of Vermont )
Talking Points
My remarks will focus on how a smaller academic institution can fill the gap between basic research and applied research. The University of Vermont has created UVM Ventures which provides a continuum of funding for projects that have a commercial potential. It has been designed in a way to maximize the probability of appealing to funding sources or licensees beyond UVM. UVM Ventures has a unique funding composition of internal, state, and philanthropy funding. It is an example of how a smaller institution in a remote location can still attempt to move technology forward through the development cycle.
Bio
Mr. Keiller is the Director of Technology Transfer for the University of Vermont. He also handles the technology transfer for Maine Medical Center, Caritas St. Elizabeth’s Medical Center of Boston, and Boston Biomedical Research Institute. He has worked for 16 years in the industrial sector in a variety of sales, marketing, and business development roles, 10 of which were with Corning. He has over 17 years of academic licensing experience and is the former Vice President, Ventures of the Brigham and Women’s Hospital in Boston. Todd has contributed to the founding of 7 companies in the life sciences field. He holds an AB from Dartmouth College and an MBA from the Tuck School of Business Administration.
_______________________
JP Kim
( Director & Policy Officer, Division of Extramural Inventions & Technology Resources (DEITR), Office of Policy for Extramural Research Administration (OPERA), Office of Extramural Research (OER), National Institutes of Health )
Talking Points
NIH is the steward of medical and behavioral research for the Nation. As the federal government’s foremost sponsor of biomedical research, NIH is interested in furthering research to benefit the public and accelerating the pace of how research results reach the public. The NIH Office of Extramural Research (OER) is the primary point of contact for NIH funding recipients for policies and related guidance, as well as for program coordination, compliance, and electronic research administration for research and training programs conducted through extramural (grant, contract, cooperative agreement) programs. To enhance research endeavors in the community, OER provides information, resources, and outreach to help the community identify NIH funding opportunities, areas of research, and potential collaborators, and to help the research community better understand and comply with the federal requirements and policies associated with federal funding. Such resources include the NIH Guide for Grants and Contracts, Computer Retrieval of Information on Scientific Projects (CRISP), iEdison, and others.
Bio
Mr. Kim serves as Director and Policy Officer of the Division of Extramural Inventions & Technology Resources (DEITR) in the Office of Policy for Extramural Research Administration (OPERA) under the Office of Extramural Research (OER) at the National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services (DHHS) and the Public Health Service (PHS). Prior to joining OER in 2005, he served for 10 years in the Office of Technology Transfer under the NIH Office of Intramural Research (OIR) as a Technology Licensing Specialist, Patent Advisor, and Technology Transfer Policy Specialist for inventions arising out of the NIH’s Intramural Research Program. Prior to coming to the NIH, he worked as a Cancer Researcher at the George Washington University Medical Center and School of Medicine and Health Sciences, as well as a Researcher at several biomedical/biotechnology companies in the Washington-Metropolitan area. In addition to direct research experience, he has also worked as a scientific/technical consultant on domestic and international patent and trademark prosecution matters at various national and international intellectual property law firms. He is an attorney admitted to practice before the U.S. Patent and Trademark Office (USPTO) of the U.S. Department of Commerce, the Maryland courts, the U.S. Court of International Trade, the U.S. Court of Appeals for the Federal Circuit (CAFC), the Supreme Court, and other courts, and has published articles on technology transfer and research issues in scientific, business, and grants management publications. He holds a B.A. (Psychology) and a B.S. (Zoology with Chemistry minor) from George Washington University, an M.B.A. (International Business and Marketing) and a J.D. (focusing on International Trade and Intellectual Property Law) from American University, an M.Sc. (Biotechnology) from Johns Hopkins University, an M.A. in Liberal Studies with a focus on Social/Public Policy from Georgetown University, as well as having additional graduate study in genetics, EU law, management, and public policy.
_______________________
Steve Kozak
( President, Greater Baltimore Technology Council )
Talking Points
Created by the Greater Baltimore Technology Council (GBTC) in 2002, MoshPit! provides an opportunity for students from Maryland colleges and universities to experience every aspect of starting a business. Student participants learn how to form a qualified team, write a competitive and realistic 2-5 page business plan, and present their ideas in a concise and clear format. And of course, there are the cash prizes – a total of $30,000 for the winning teams. Why participate? It’s fun and it provides the ‘real world’ experience that looks great on a resume. Additionally, besides the practical knowledge the experience brings, students will also make connections with some of Maryland’s top tech entrepreneurs, businesspeople and venture capitalists who will act as your “advisors” as you develop your business plans. These individuals can be an invaluable resource in a post-graduation job search or business launch. And, candidly, you never know where this experience will take you. At the very least, you'll be better positioned to launch that business down the road.
Bio
Steve Kozak became Executive Director of the Greater Baltimore Technology Council (GBTC) in March 2005 after serving as the GBTC’s Assistant Director since June 2001. During Steve’s tenure as Executive Director, the GBTC has grown substantially. Today, the organization offers more than 200 programs, forums and roundtables, while membership has jumped nearly 23 percent over the past two years. As Executive Director, Steve has been instrumental in expanding and strengthening collaborations with other regional business and technology organizations. Under his direction, the GBTC forged a strategic alliance with the Tech Council of Maryland, helping to advance Maryland’s national stature as a hotbed for technology growth. The GBTC has also continued to provide member-driven programs and forums where people meet, learn and do business, while spreading the word that technology and the entrepreneurial spirit thrive in Greater Baltimore. Many of those programs – including such major initiatives as MoshPit and TechNite – have been recognized both locally (The Daily Record’s Innovator of the Year Award) and nationally (The Public Relations Society of America’s Silver Anvil Award). Steve has also been responsible for launching a number of new initiatives, including GBTechNet, the GBTC Golf Classic, networking events such as the GBTC’s regular Wine Tastings (winner of Baltimore Magazine’s Best Places to Network Award) and a series of Executive Roundtables. A member of the UMBC President's Advisory Council (PAC) and Emerging Technology Center’s Board of Directors, Steve is known throughout the region’s business community for the passion he brings to his post. He believes in the GBTC and in its mission to grow Greater Baltimore’s tech community. His enthusiasm has earned the respect of the GBTC’s members, its board, and the leadership at the Maryland Department of Business and Economic Development (DBED), the GBTC’s funder and partner. Prior to joining the GBTC, Kozak was Director of Business Development for Gilden Integrated, a Baltimore area ad agency. Previously, he held positions as a business analyst, product manager, and marketing manager for PHH Vehicle Management Services in Hunt Valley, Maryland. Kozak earned his bachelor’s degree in marketing from the University of Maryland, College Park and an MBA from Loyola College.
_______________________
Steven Kubisen
( Senior Director, Johns Hopkins University )
Talking Points
Johns Hopkins University is the largest research institution in the country and is located in Maryland, which leads the nation in research funding. To better unlock the potential for innovation into various commercial markets, we must continue to grow our university’s and the region’s capacity for developing new ventures. This panel will discuss a developing private/public partnership between private angel investors, private and public research institutions, and state agencies to grow the support for early stage technology ventures in greater Maryland.
Bio
Steve joined Johns Hopkins Universit
( Associate Director of Advancement, The George Washington University )
Talking Points
At George Washington University, alumni are becoming "angel investors", making personal investment in early stage companies. By matching alumni investors with faculty, student and alumni-run companies, the value creation stays within George Washington and sets the stage for significant gifts to the University, equity in the new company, and commercialization of technologies developed in University labs. This type of activity engages some of the most affluent members of the alumni body in a sustained and often lucrative way. As a result, our alumni come back and remain committed to our school.
Bio
Jeremy L. Adelman is the Associate Director of Advancement at The George Washington University’s School of Engineering and Applied Science. During the 10 years he has spent as a manager and fundraiser in universities and nonprofit organizations, he has worked primarily with high tech business leaders and entrepreneurs as volunteers and donors. Notable accomplishments have been building an alumni angel investors network, and bringing in multiple million dollar donations from corporations and individuals. Mr. Adelman holds both an MBA from the Heller School of Social Policy and Management, and an MA in Nonprofit Professional Leadership from Brandies University, as well as a BA in Philosophy from the University of Utah.
_______________________
Paul Ahlstrom
( vSpring Venture Capital )
_______________________
Anna Amar
( NIAID, NIH )
Talking Points
Other than its own published research, the National Institutes of Health (NIH) is perhaps best known for funding biomedical studies through grants and contracts. However, when looking to NIH as a resource – the 27 institutes and centers that make up the NIH have an extensive collection of hidden “treasures” that are often available to both non-profit and for-profit organizations. NIH is making available these resources with the goal of assisting in the development of the environments and tools needed to understand, detect, treat, and prevent a wide range of diseases in order to better public health. The many materials and services that are accessible include:
- Clinical Trial Networks and General Clinical Research Centers
- In Vitro Screening Services (including High Throughput)
- Assistance with production, bulk supply, GMP manufacturing & formulation
- Pharmacokinetic testing and animal toxicology
- Independent product development planning expertise
- Animal efficacy studies
- Biomedical technology resource centers
- Clinical-grade gene vectors
- Human tissue, organ, and islet cell repositories
- Vertebrate and invertebrate animal models repositories and stocks
- Biological Material Repositories (including biodefense)
- Comparative medicine information sources
- Genetic and genomic resources
- Molecular Libraries
Bio
Anna Z. Amar is currently the Lead Technology Development Associate for the Extramural Technology Development and Transfer Branch of the Office of Technology Development (OTD), National Institute of Allergy and Infectious Diseases (NIAID) at NIH. Anna joined OTD in January, 2003, having come from the Laboratory of Immunology, NIAID, where she had held a research position since 1995. Anna received her B.S. (Hons.) from Murdoch University in Australia, where she also undertook post-graduate training and was employed in the fields of immunology and molecular biology. While continuing her Ph.D. research in the States, she worked in the Laboratory of Molecular Genetics at the University of South Florida. Anna has been an active member of the NIH Technology Development Coordinator’s (TDC) Community having chaired the TDC Training Working Group, the NIAID Agreements for Clinical Trials Working Group, and having participated in the TDC Marketing Working Group as well as the Training and Education Subcommittee of the Technology Transfer Policy Board. Anna has recently been invited to speak at such forums as the Biotechnology Industry Organization (BIO) Convention and the American Conference Institute (ACI).
_______________________
Ali Andalibi
( Program Director, SBIR/STTR, National Science Foundation - NSF )
Talking Points
Our nation’s universities are the often the birthplaces of transformative ideas that can be of great benefit to society. Too often however, the flow of these important discoveries towards the marketplace is slow and indeed many times, the discoveries never leave the university. The goal of this conference is to bring together university decision-makers and members of the investment community, in addition to federal and state representatives in order to find ways of accelerating the movement university-based findings from laboratories into start-ups.
Bio
Dr. Ali Andalibi is a molecular biologist and geneticist by training with extensive experience in both academia and industry. He received his PhD from the UCLA department of Microbiology and Molecular Genetics and later joined the faculty in the UCLA department of Medicine. After leaving UCLA he was involved in several early stage biotechnology companies. He then joined the House Ear Institute (HEI), where he is the Director of New Technology and Project Development. He is also an adjunct Assistant Professor of Otolaryngology, at the University of Southern California, School of Medicine. Dr. Andalibi is currently on leave from HEI/USC and serving as a Program Director at the National Science Foundation.
_______________________
Meg Arnold
( Director, Business Development & Entrepreneurship, UC Davis InnovationAccess )
Talking Points
At UC Davis, as at a growing number of universities across the country, we actively seek to foster entrepreneurship across the campus, among faculty, graduate students and post-docs in the full range of disciplines. The UC Davis Center for Entrepreneurship at the Graduate School of Management has developed innovative approaches to integrating graduate-level scientists and MBA students into a year-long study of commercialization and entrepreneurship. In addition, administrative units including UC Davis InnovationAccess provide other services focused on entrepreneurship. This model of close collaboration and cooperation among different units is representative of the inter-disciplinary approach to research and education at UC Davis.
Bio
Meg Arnold is the Director of Business Development & Entrepreneurship at UC Davis InnovationAccess, and has developed numerous programs to foster entrepreneurship on campus and in the Sacramento region. Meg came to UC Davis in 2002 as Manager, Entrepreneur Development at UC Davis CONNECT, and was promoted to Director, UC Davis CONNECT in 2005. In March, 2007, UC Davis CONNECT became UC Davis InnovationAccess, in an expansion of UC Davis's commitment to entrepreneurship on campus. Reflecting this commitment, a fundamental shift in UC Davis’s approach to startup companies and entrepreneurship has generated nearly 20 new start-up companies from research activities underway on campus. Before joining UC Davis, Meg spent ten years in the telecommunications industry, working primarily in strategic planning and business development for AT&T Canada, in Toronto, and British Telecom (BT), in London. In these roles, her work focused on mergers and acquisitions, strategic and joint ventures; in addition, at BT she worked to coordinate a single product platform for Internet-based business services across Europe. She was also involved with the then-largest telecom acquisition in Canada, and the corporate restructuring and spin-off program of BT in 2001-02. Meg has an MBA in Finance from the University of San Francisco, and a BA in English from Cornell University.
_______________________
Daniel Behr
( Director Business Development, Harvard )
Talking Points
How to be an effective "venture catalyst" within the university setting; How to address the commercialization / funding gap.
Bio
Daniel Behr co-founded 4 technology companies, was a general partner in a seed-stage venture fund, and serves as director/advisor to several start-ups. He is currently a “venture catalyst” at Harvard University where he is Director of Business Development in the Office of Technology Development. Daniel was co-founder of IN USA which became a $10M world leader in ozone instrumentation; Compact Instruments, which developed the world’s first hand-held mass spectrometer and was acquired by MKS Instruments (NASDAQ:MKSI) in 2000; Arradiance, which is developing an electron-beam source for use in semiconductor lithography (funded by top-tier VC funds in November 2004); and Growth Point Life Sciences, a firm focused on accelerating the commercialization of intellectual property assets. His seed-stage angel fund, Seed Partners, was founded in 1999 and is fully invested in a portfolio of start-up companies. Daniel is a Director of Nutfield Technology (industrial lasers) and an advisor to companies commercializing new medical devices, instruments, nano technologies, and software products. Daniel earned an MBA with Distinction from the Harvard Business School and an engineering degree with Highest Honors from Georgia Tech, and is fluent in Spanish and German.
_______________________
Rob Bettigole
( Managing Partner, Elm Street Ventures )
Talking Points
Key catalysts for successful technology-based start-ups are the involvement of seasoned management and access to professional investment capital. Elm St Ventures is a seed and early stage venture fund, primarily (but not exclusively) focused on the life sciences. Our partners have substantial experience in starting, funding, and operating companies, and as we approach early stage investing as a hands-on undertaking, we prefer to fund businesses located within roughly an hour and a half’s drive of our office.
Bio
Rob Bettigole has broad experience as an entrepreneur and as a venture capitalist. His venture capital experience was gained as a partner at Rothschild Inc. and Investor AB, where his investments included Maxim Integrated Products, Gensia Pharmaceuticals, and Microgenics Corporation. Subsequently, he helped found Surety Technologies, Inc., a spin out from Bellcore, and Alexion (NASDAQ: ALXN), with researchers from the Yale Medical School. Before founding Elm Street, Mr. Bettigole was president of a business serving the infrastructure (bridge and highway) market, which he successfully developed and sold. Mr. Bettigole has a BS in Engineering and Applied Science from Yale University and an MPPM from the Yale School of Management, where he is an Entrepreneur-in-Residence. He is a Licensed Professional Engineer and holds several U.S. and foreign patents.
_______________________
Jack Biddle
( Co-founder, Novak Biddle Venture Partners )
Talking Points
For seasoned venture capitalists who understand both the science and the art of building a company around an idea, universities can provide excellent deal opportunities. However, several variables come into play that influence a start-up’s attractiveness including scalability, market opportunity, and potential dual use of a technology. My comments will focus on NBVP’s strategy for determining which start-ups are appealing from a VC’s perspective and why we pass on other opportunities.
Bio
Jack co-founded Novak Biddle Venture Partners in 1996. From 1990 to 1995 he was President and CEO of InterCAP, a venture backed computer software company with 100 Fortune 500 clients. InterCAP was number 18 on the "Fast 50" list of the mid-Atlantic's fastest growing companies. It was profitably acquired by Intergraph in 1995. From 1987 to 1990, Jack rose from Senior Associate to Partner at Vanguard Atlantic, Ltd., a merchant banking group focused on M&A advisory work and control investments in software companies on the firms own account. At VAL, he served as CEO or COO of several portfolio companies. Earlier in his career he was an IT Industry Generalist, focused on telecommunications technology, at the Gartner Group, where he was also Executive Assistant to the CEO, Gideon Gartner. He began his career in 1983 in Austin, Texas at Business Development Partners, an early stage venture capital partnership. Jack holds a BA in Economics from the University of Virginia. Jack currently serves on the boards of Vision Chain, CorasWorks, Triumfant, eMinor and Digital Sports. Past board or observer seats include SafeView, Inc. (acquired by L3 Communications), Matrics (acquired by Symbol Technologies), Giga Information Group (Nasdaq: GIGX. Lead Director), acquired by Forrester, Telogy Networks, (acquired by Texas Instruments), Tantivy (acquired by Interdigital), AnswerLogic (acquired by Primus Knowledge Systems), and Blackboard, Inc. (Nasdaq: BBBB). He is a Director of the Computer & Communications Industry Association, and is a member of the Naval Research Advisory Counsel for the Office of Naval Research. Jack has previously served three years as co-chair of MAVA's Capital Connection Selection Committee. He is on the Investment Committee of the New Markets Growth Fund, an SBA leveraged fund associated with the University of Maryland targeting development oriented private equity investments in disadvantaged areas. He is a frequent speaker on entrepreneurship for the U.S. Department of Commerce, and has made presentations for them in Russia, China and Japan. Jack is on the Business Advisory Council for the Montgomery County Council. Jack is a Vice Chairman on the Board of the Baltimore Symphony Orchestra and also serves on their Finance and Executive Committees.
_______________________
John Brasch
( University of Nebraska - Lincoln )
Talking Points
Towards understanding the personality characteristics of successful entrepreneurs. Is it the inventor? Or the serial startup specialist who has been defined by: "Do it my way"; "Passionate"; "Wants to do it all" ; or is it the developer who delegates and gets out of the way?
Bio
John began his working life in Lincoln as a professor in the College of Business Administration at the University of Nebraska from 1969 to 1980. While at UNL he founded International Management Services, Inc. (IMSI). With a dozen employees IMSI was as an independent export distributor for several Nebraska corporations, operating in more than 15 countries. In time IMSI evolved into Senior Technologies, Inc. (STI) with over 200 employees. STI operated as a full function original equipment manufacturer (OEM). It was the leading brand marketer of electronic safety products used in institutional care of the elderly. After selling the company to the Stanley Works, an S&P 500 company, in 2002, John continued as CEO of Stanley Senior Technologies. M&A was a significant part of his responsibility while with Stanley. John is the board president of Family Service Lincoln, a member of the Lincoln Partnership for Economic Development. He is married to Beatty, has two children and two very young grandsons.
_______________________
Larry Brown
( Co-founder, Sensics Inc. )
Talking Points
I will discuss my experiences in starting Sensics: how the key technology originated, the path to securing rights to the technology, types of funding secured and future plans.
Bio
Larry left the Johns Hopkins Wilmer Eye Institute with his co-founder in 2003 to start Sensics. Sensics spent its first three years making a production version of the original technology, raising approximately $1M through R&D contracts and angel investment. The company has now booked approximately $1.2M in product revenue since launching the first product just over one year ago. Sensics is growing, but currently has five employees and many well-known customers in North America, Europe, Australia and Asia. Larry earned a Ph.D. from the Johns Hopkins University in 1997, where he specialized in vision science. Dr. Brown has also completed a post-doctoral fellowship at the Wilmer Eye Institute, served on the board of the Baltimore Chapter of the Project Management Institute, and participated in the MindShare program. MindShare is an invitation-only program that selects the most promising high-tech business leaders in the greater DC area and provides coaching and mentoring on start-up success. Larry has also worked as project manager and a programmer, writing code for biological neural networks, particle physics experiments, credit score processing applications and web applications.
_______________________
Mark Burns
( Vesbridge Partners )
Talking Points
I will talk about working with our portfolio companies (including university start ups) on moving from the start up phase to an established company through the creation of an infrastructure designed for growth, building effective management teams and accelerating the business development process.
Bio
Mark joined Vesbridge in 2004 from St. Paul Venture Capital (SPVC) (our predecessor firm) and if focused on investments in information technology. He manages the firm’s resource network, leads the firm’s management team building initiatives and is responsible for the firm’s efforts in accelerating business development on behalf of our portfolio companies. Prior to SPVC, Mark was a manager in the consulting practice of Vitale, Caturano & Co., a full service CPA and consulting firm. Prior to Vitale, Mark spent 10 years at Arthur Andersen in the Boston office.
_______________________
Melissa Carrier
( Director of Venture Investments, University of Maryland, Dingman Center for Entrepreneurship )
Talking Points
Angel investors are a critical component of economic development and business creation in the United States. With total investments of $25.6B last year, angels continue to rival Venture Capitalists. Additionally, angel investors are continuing to be sophisticated in the way they approach the market, self-organize, and negotiate deals. At the University of Maryland, our Capital Access Network program provides open and efficient access to early-stage angel capital for entrepreneurs in the DC Metro area. Additionally, our University of Maryland Alumni E-Fund invests in student, faculty, and alumni-run businesses, where returns are directly reinvested in our programs.
Bio
Melissa Carrier joined the Dingman Center in 2006 after 11 years of leading organizational growth for technology companies ranging from Fortune 500 to early stage start-ups. Ms. Carrier brings broad experience across corporate and product-line positions including acquisitions and divestitures, venture investments, partnerships, new product launches, system implementations and marketing programs. Melissa previously served as Finance Director for AT&T Mergers and Acquisitions. While at AT&T, she also led investments for the company's Strategic Venture fund. In this role, Melissa had lead responsibility for managing the investment pipeline, analyzing financial and market data, performing on-site due diligence, and executing deals. During her tenure at AT&T, she also served as the Product Manager for the MVNO wireless data content offering/platform as well as Manager of Strategy and Business Development for AT&T Consumer Services. Ms. Carrier began her career as a process consultant for Andersen Consulting. During this time, she worked with U.S. and European clients on business process design and ERP system implementations. Subsequently, Ms. Carrier served as a Director at two startup technology companies focused on web-based business-to-business strategies. Immediately prior to obtaining her MBA, Melissa led strategic development of core processes for SAP's Global Solution Center. Ms. Carrier received a BS in Chemical Engineering from The Ohio State University and an MBA with Honors in Finance and Strategic Management from The Wharton School of The University of Pennsylvania.
_______________________
Dean Chang
( Director, Technology Ventures, University of Maryland )
Talking Points
I will talk about the anatomy of a Great Biz Plan Competition and Which Biz Plan Competitions Really Work And Why.
Bio
Dean oversees all the MTECH Ventures and Education programs, including: the TAP venture incubator, VentureAccelerator, the University of Maryland Technology Start-Up Boot Camp, the University of Maryland $50K Business Plan Competition, the Hinman CEOs Program, and other educational entrepreneurship offerings at the University. Dean previously held the dual roles of Chief Technology Officer and Vice President of Gaming Business at Immersion Corporation, a company he helped guide over ten years from a four-person, venture-backed, Silicon Valley startup to a $200M publicly traded technology leader (NASDAQ: IMMR). As general manager, Dean was responsible for strategic direction, sales and marketing, and operations of licensing Immersion's vast patent portfolio to the video game industry. Dean has written articles for Computer Magazine, BusinessWeek Online, and GameDAILY BIZ, and has been a speaker at executive, leadership, and press technology forums. He holds 30 U.S. and international patents in the field of haptics. Dean was a Pi Tau Sigma graduate from MIT; he holds a B.S. in mechanical engineering from MIT, as well as both an M.S. and Ph.D. in mechanical engineering from Stanford University. He also holds an MBA with honors, and received the highest distinction of Palmer Scholar from the Wharton School of the University of Pennsylvania.
_______________________
Matthew Christensen
( University of Wisconsin-Madison )
Talking Points
I plan to give a "users" view of various regional programs for university start-ups in the Mid-West. I will elaborate on what resources have proven helpful for entrepreneurs at universities in the region.
Bio
Matthew Christensen is currently a graduate student in medical physics at the University of Wisconsin-Madison working towards his PhD. Matt has taken advantage of several opportunities for aspiring entrepreneurs in the Mid-West region, including participating in the G. Steven Burrill business plan competition at UW, winning first prize in the MIT Enterprise Forum of Chicago Whiteboard competition, competing in the Midwest Emerging Companies Showcase and completing the first ever Wisconsin Entrepreneurial Bootcamp at UW. Matt has co-founded Medical Imaging Sciences, which plans to commercialize technology for GI disorders and is currently in the process of patenting through WARF. He also holds a BS in biomedical engineering from Boston University.
_______________________
Tom Churchwell
( Managing Partner, ARCH Development Partners )
Talking Points
I will speak to our experience in seed funding university spin outs in the Midwest which has been our focus for a number of years.
Bio
Thomas L. Churchwell is Managing Partner of ARCH Development Partners L.L.C., a very-early stage venture partnership which specializes in the creation and funding of high-tech companies in the Midwest. Previously, he was President and CEO of ARCH Development Corporation, a subsidiary of the University of Chicago, which commercialized technology from the University and Argonne National Laboratory. Prior to that, he was President and CEO of Calgene Fresh, Inc., a 1992 start-up company which produced and marketed the MacGregor’s FLAVR SAVR tomato, the world’s first biotech food product. Prior to joining Calgene Fresh, Mr. Churchwell was Vice President of ARCH Development Corporation Development. Before starting Calgene Fresh, Mr. Churchwell held several senior management positions at the NutraSweet Company, including Vice President, Sales and legal positions at G.D. Searle & Co., American Hospital Supply Corporation and The Coca-Cola Export Corporation. Mr. Churchwell is a director of TiE Midwest, Chicagoland Entrepreneurial Center, iBio, the Illinois Venture Capital Association, and number of start-up companies in the Chicago area. He holds a BA degree from DePauw University and JD degree from Northwestern University School of Law. He also is a Graduate of the Advanced Management Program at Harvard Graduate School of Business Administration.
_______________________
Edward Clancy
( National Science Foundation )
_______________________
Don Clark
( General Manager, NEC Corporation of America )
Talking Points
I will discuss technology transfer and business development from a corporate perspective. As one of the largest commercial research organizations in the world, NEC faces many of the same challenges as universities do in turning innovations into business success. I will share our experiences spinning in new business from our research organizations, spinning out new venture back businesses, and licensing technology.
Bio
Don Clark is General Manager of Corporate Planning for NEC Corporation of America. He leads the Strategy, Venture Relations, Corporate Development and Licensing activities for NEC in the United States. Don has led licensing transactions in diverse areas as video analysis, performance analysis software and nanotechnology. Don received his BA from UC Davis and is a Chartered Financial Analyst.
_______________________
Michael Cleare
( Associate Vice Provost for Research and Executive Director Technology Transfer, University of Pennsylvania )
Bio
Dr. Cleare worked for 30 years at Johnson Matthey, a UK based multinational world leader in advanced materials technology prior to joining Columbia/STV in August 2000. His experiences range from the Senior R&D Executive through Business Development to a range of senior business management positions, and included serving on the main Board of the Company for four years. While in R&D he was involved in the discovery and development of a major new class of anti-cancer drugs (platinum based - particularly carboplatin). He served as President of several of the company’s major divisions, including Pharmaceutical Materials, Chemicals and Metals, Catalytic Systems and Electronic Materials. He has managed complex global businesses, negotiated and closed multi-million dollar licensing and technology transfer deals, and entered into multiple research funding agreements with major universities. From 2000-7 Dr Cleare was the Executive Director of Science and Technology Ventures at Columbia University in New York. This position included responsibility for all Technology Transfer activities at Columbia and involved licensing, spin off/Start up companies , Industrial Research funding and Domestic and International partnerships relating to IP. He reported to the Senior Executive Vice President. In August 2007 he joined the University of Pennsylvania as Associate Vice Provost for Research, responsible for all Technology transfer, IP management and industrial liaison activities. For nine years, Dr. Cleare was a member of the board of directors of the Canadian biotechnology company, AnorMed.
_______________________
Ronald Cooper
( Senior Policy Analyst, U.S. Small Business Administration )
Bio
Ronald Cooper is Senior Policy Analyst of the U.S. Small Business Administration’s Office of Technology. He conducts economic and policy analysis on issues related to technology innovation and small business, and provides management and oversight of several federal innovation programs including the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, and until recent years, the Federal and State Technology Partnership (FAST) program. In this position, Dr. Cooper works on a range of innovation policy issues with the Administration, Congress, state governments and organizations, NGOs that provide business assistance or regional development services, individual small businesses, and industry groups including venture capital and small business associations. Dr. Cooper holds a Ph.D. in Economics; has published articles and books in the areas of technological innovation, economic policy, and economic development; and has lectured on these topics in the United States, Europe and Latin America.
_______________________
Paul Cummings
( Principal, Honda Strategic Venturing )
Talking Points
I will talk about early stage investment from a corporate/strategic viewpoint. In this context, I will discuss how early stage companies can benefit from joint development activities with a corporate investor to evolve early stage technologies to commercial products.
Bio
Paul Cummings is a Principal of Honda Strategic Venturing (HSV), the corporate venture capital arm of Honda Motor Corporation based in Mountain View, California. HSV seeks investment opportunities in technology venture companies to establish the strategic foundation for collaborative partnership both to excel Honda’s innovative R&D and to help technology venture companies succeed in Honda’s product markets. Prior to joining Honda, Paul held various management positions with automotive tier 1 supplier Delphi; including, positions in mergers and acquisitions, business development and operations for a Japanese partnered joint venture. Paul also worked for Accenture in the Sydney, Australia office with the Strategy Consulting Practice. Paul holds an MBA from the University of Chicago, and BA from Michigan State University.
_______________________
Brian Cummings
( Executive Director, Technology Commercialization, University of Utah )
Talking Points
There has been much debate about the creation of technology ecosystems built around Universities for the benefit of regional economic development. There are clear cut examples of this success at some of the major research institutions around the country; but is this a model that can or should be replicated by smaller universities nationwide? Too often the masses attempt to replicate the few and fail. By ripping up the traditional hierarchy at US research universities we are hoping to create a new service based model for commercialization that aligns State and Venture stakeholders and focuses efforts toward a business development approach in translating research into opportunities. You decide if it can be repeated in your region.
Bio
Brian Cummings is currently the Executive Director of the Technology Commercialization Office at the University of Utah. In the two years that he has been in this role the office has produced record revenues and successfully started 37 new technology-based companies, 80% of which have received initial funding and beyond. Brian has started three companies in his entrepreneurial career and is currently President of a University-based personalized medicine company. Previously, Brian led the life science commercialization efforts at the University of Texas and prior to that was the Director of Business Development at Micro-Bac International. Brian currently serves on the Board for The Utah Life Science Association, The Rocky Mountain Research Center for Emerging Infectious Diseases, The Governor’s Board for Business Resource Centers, The Renaissance Foundation and the LES Board for Technology Commercialization Structure and Development.
_______________________
Brian Darmody
( Associate Vice President, University of Maryland )
Talking Points
University business plan competitions increasingly are being integrated into university and regional technology-based economic development efforts. I will open the panel by briefly discussing the history of business plan competitions, linking them to the university start ups, comment on emerging trends in these competitions, and lead a discussion among the panelists on best practices, regionally and nationally. Discussion of panelists will summarize their programs, leading to discussion concerning ways business plan competitions can align themselves with start up creation, entrepreneurial education and start up experience. University Business Plan Competitions: The New Look.
Bio
Brian Darmody is Associate Vice President for Research and Economic Development at the University of Maryland. He has been involved with launching the University's Office of Technology Commercialization, the Maryland Technology Development Corporation (TEDCO), Research Parks Maryland (RPM) and other technology development entities. Previously he worked as University General Counsel, Director of University Government Relations, and at US Health Care Financing Administration, US House of Representatives and Maryland General Assembly. For 2007-08 he chairs the University Network of Entrepreneurs (UM NET).
_______________________
Vinse Davidson
( Partner and Chief Financial Officer, STARTech )
Talking Points
Role of Collaboration in University Commercialization Spinout Entities. Although it is very hard to commercialize research, collaboration of the University’s researchers, departments and transfer professionals with the business managers, government and investors interested in commercialization can reduce the risks and improve returns. It is important to understand and address the different needs of the parties in evolving a promising technology into a successful enterprise and a model emphasizing the value of collaborative efforts will be discussed.
Bio
Vinse Davidson serves as the Chief Financial Officer for STARTech with responsibility for the finance, accounting, reporting and facilities functions. He has over 20 years of business experience, with significant roles in the financial and operational aspects of real estate, computer systems management, and infrastructure construction. Before joining STARTech, he assisted start-up stage companies as an interim CFO. His career includes work for MasTec, Inc., a national construction company, as Division President and at Trammell Crow Company as CFO of their Dallas Industrial Division. He has also provided independent consulting services that included supporting business sales, operational systems analysis and training. Vinse began his career in the Dallas office of what is now Ernst & Young. He holds a Bachelor's degree in business from the University of Tennessee at Martin and a Master of Professional Accounting degree from The University of Texas at Austin. He is a licensed CPA.
_______________________
David Day
( Director, University of Florida )
Talking Points
Mr. Day will outline how to organize angel funds from the perspective of a niversity technology transfer office. He will also brief the audience on the value and techniques of working with a univeristy's benevolent foundation. Finally, he will detail legislative initiatives in the star of Florida to support new start-up creation.
Bio
David L. Day joined the Office of Technology Licensing at the University of Florida as Director on April 2, 2001, where he oversees the commercialization efforts of all UF technologies. Mr. Day also serves as Director of the Sid Martin Biotechnology Incubator in Alachua, FL, since 2003. Mr. Day serves on the Board of Directors of BioFlorida, the McKnight Brain Institute Advisory Panel, the Board of Directors Executive Committee of the Florida Research Consortium, and the board of Directors Executive Committee of the Southeastern Bio Investors Forum. From 1995 to 2001, he served as the Director of the UAB Research Foundation at the University of Alabama at Birmingham. David received a Master of Business Administration from the University of Alabama in 1987 and has a Masters of Library and Information Studies from the University of Alabama, 1977.
_______________________
Robert Diamond
( Manager, Marketing and Business Development, Montgomery County, Dept of Economic Development )
Talking Points
Where did the technology originate? How did you and your organization secure it? How did you fund the initial acquisition of the technology and start-up of your business? What were the steps you took to move your product along in development? When did you commercialize your first product? What steps did you take to move from R&D to commercialization? What follow-on funding did you acquire and how? Where is your technology now? Is it revenue producing? What are your plans for the future of your current technology or the acquisition of others? What lessons have you learned and would you do it differently if you could?
Bio
Bob Diamond began his professional career as an MIS programmer with IBM’s Federal Systems Division in Owego, NY. Bob advanced through a number of technical and management positions with IBM divisions in Gaithersburg and Bethesda, Maryland and Boca Raton, Florida. Returning to Maryland in 1994, Bob joined Manugistics Inc. Bob held a number of senior management positions within the company, including Vice President, Corporate Services, where he had responsibility for the company’s global Information Technology, Security and Real Estate organizations. In 2001, the Manugistics’ IT organization was named to Computerworld’s list of 100 Best Places to work in IT. In January 2006, Bob received a special appointment to become Assistant Secretary for Business Development, Department of Business and Economic Development, for the State of Maryland, where he led a team responsible for attracting and nurturing businesses into and in the State. In January 2007, Bob was appointed to the Montgomery County, Maryland Department of Economic Development, where is the Director of the Marketing and Business Development division. Bob has served on the Board of Directors of the Technology Council of Maryland and Norbeck Country Club. He chairs the President’s Advisory Council on Business Outreach for the University of Maryland, Baltimore County (UMBC), where he is also a part-time Information Systems Department instructor. Bob is a charter member of the CIO Roundtable of Montgomery County. Bob is a graduate of the state University of New York at Binghamton. He lives in Derwood, Maryland with his wife. His daughter is a public school teacher in Mount Airy, Maryland, and his son is student at Penn State.
_______________________
Allen Dines
( Assistant Director, UW-Madison Office of Corporate Relations )
Talking Points
Universities are exploring a wide variety of novel ways to increase the number and quality of startup ventures based on the research accomplishments of their faculties. The Midwest Research University Network (MRUN) was formed in the belief that through regional cooperation, these objectives could be further enhanced and regional benefits would accrue to individual universities in the network. How are universities actually fostering growth of their startups through regional cooperative efforts? This panel and my talk will provide examples of several MRUN initiatives that are producing favorable results.
Bio
Mr. Dines is Assistant Director of the University of Wisconsin-Madison Office of Corporate Relations (OCR). Operating within the Office of the Chancellor, the Corporate Relations office assists the business community in accessing the diverse resources of the University of Wisconsin-Madison (UW-Madison). As Assistant Director, he serves as Program Manager for OCR’s entrepreneurship programs including its Startup Initiative and the UW-Madison Kauffman Campus-wide Entrepreneurship program. Mr. Dines joined the UW-Madison in 2001 bringing with him more than 25 years of experience in industry and technology management. He founded, grew and sold two biotech startups and in his initial position at the university he served as Assistant Director for Business Development, within the Graduate School where his major focus was commercialization of university technology through startup business development. In 2002, Mr. Dines co-founded the Midwest Research University Network (MRUN), an alliance of Midwest research institutions dedicated to regional cooperation in the commercialization of university research through new business creation.
_______________________
Mark M. Ellison
( Director, Emerging Technology Program, Office of the Governor, Texas )
Talking Points
A new day in TEXAS! - Shifting from Technology Transfer to Technology Commercialization within Texas Universities.
Bio
Mark M. Ellison is the Director of the Emerging Technology Program for the Office of the Governor Economic Development and Tourism. His extensive experience in the private and public sector complement his leadership of initiatives that establish strong ties with industry and ensure strong business involvement. Before joining the Governors Office Mark M. Ellison held the position as Director of the Office of Employer Initiatives for the Texas Workforce Commission. Before joining TWC Mr. Ellison was a partner in a specialty investment banking firm in Dallas. As Assistant Commissioner of Marketing and Agribusiness Development for the Texas Department of Agriculture (TDA) for then, Commissioner Rick Perry, he led domestic and international marketing and economic development efforts for the Texas Department of Agriculture. Mr. Ellison has also served as international trade specialist for U.S. Wheat Associates in Washington D.C. and Casablanca, Morocco, then continued in Casablanca as a marketing specialist. Returning to Washington, D.C. as an international trade policy consultant, his clients included the retailing, consumer electronics and agricultural commodity industries. Mr. Ellison is a member of the Texas Economic Development Council (TEDC) and the International Economic Development Council (IEDC). He earned a bachelor of Science degree cumlaude in Agriculture from Texas A&M University.
_______________________
Steve Ferguson
( Director, National Institutes of Health )
Talking Points
As a healthcare agency and a major sponsor of university research, NIH is also interested in accelerating the pace of how such research results reach the public. University-based biomedical start-ups should not overlook the benefits of interacting with the NIH and other federal labs, not the least because of non-dilutive funding, technical assistance, opportunities for collaboration, new technology sourcing or even as new customer.
Bio
Steven M. Ferguson currently serves in the NIH Office of Technology Transfer as the Director of the Division of Technology Development and Transfer, the patent & licensing group for NIH and FDA technologies. Prior to joining NIH Office of Technology Transfer in 1990, Mr. Ferguson served in marketing and management positions in biomedical firms subsequent to being a scientist at the National Cancer Institute. His healthcare experience has also included work as Director of Marketing and Public Relations for a rural 70-bed hospital. Registered to practice before the USPTO, Mr. Ferguson also holds Master's Degrees in Business Administration (George Washington University) and Chemistry (University of Cincinnati) as well as Bachelor’s Degree in Chemistry (Case Western Reserve University). Mr. Ferguson has been an economic reviewer for Maryland Industrial Partnerships (MIPS) as well as the Advanced Technology Program (ATP) grant programs and is an instructor for both the USDA Graduate School and the NIH FAES Graduate School where he also the department chair for the new Certificate in Technology Transfer Program. Mr. Ferguson was also the Susan T. and Charles E. Harris Visiting Lecturer at the Watson School of Biological Sciences at the Cold Spring Harbor Laboratory and has published articles on licensing and technology transfer issues in such publications as Journal of Biolaw and Business, Journal of Pharmaceutical Development & Regulation, Drug Discovery Today, Personalized Medicine, Nature Biotechnology, AUTM Journal and Current Drug Discovery Technology. He is also the co-author of Starting & Operating A Business in the District of Columbia and Starting & Operating A Business in West Virginia. He has received the NIH Director’s Award and six NIH Merit Awards in recognition of his activities in the management and negotiation of technology licensing agreements for the National Institutes of Health.
_______________________
Mark Frantz
( RedShift Ventures )
Talking Points
I will talk about that technology transfer from universities, either start-ups or licensing opportunities, helps drive innovation in our country and across the globe. While good work has been done to date, the more we can do to further encourage the activities, the more likely we are to have a vibrant, robust economy for decades to come.
Bio
Mark is focused on software and media investments for RedShift Ventures and currently serves on the Board of Directors at portfolio companies Intelliworks and TerraGo Technologies. Mr. Frantz also serves on the Board of Directors at ODIN Technologies, the Northern Virginia Technology Council (NVTC) and the Commonwealth of Virginia's Research & Technology Advisory Council (VRTAC). Mark has also been an investor/advisor to New Media Strategies (acq. by Meredith Corp., NYSE - "MDP"), Sourcefire (Nasdaq - "FIRE"), Luna Innovations (Nasdaq - "LUNA") and American Teleradiology Nighthawks (acq. by Nighthawk Radiology Services, Nasdaq - "NHWK"). Mr. Frantz was previously the Managing General Partner of In-Q-Tel, the strategic venture capital affiliate of the U.S. Intelligence Community. Prior to that, Mark was with Carlyle Venture Partners, where he worked with Blackboard (Nasdaq - "BBBB"), Imagitas (acq. by Pitney Bowes, NYSE -"PBI"), ISR Solutions (acq. by Stanley Works, NYSE - "SWK"), Panasas, Grant Street Group and Secure Elements. Mr. Frantz joined Carlyle from Redleaf Ventures, where he worked with various portfolio companies including Lightningcast (acq. by AOL/TimeWarner, NYSE - "TWX"). Prior to Redleaf, he was the Associate to the Senior Chairman of Alex. Brown and he worked extensively with the Technology and Internet groups. Mark has also served as the Associate Director of The White House Office of Intergovernmental Affairs under President George H. W. Bush and as the economic and technology policy advisor to Pennsylvania Governor Tom Ridge, where he came up with idea for the early-stage venture capital fund that is now known as PA Early Stage Partners. Mr. Frantz is actively involved in the community, having served as the Co-Chair of the Greater Washington Board of Trade Technology Transfer Task Force, a member of the Advisory Committee on Technology Transfer to the Virginia Joint Commission on Technology & Science, Accelerating Innovation/Tech Transfer 2005, the 2002 & 2003 "Technology Transfer in the Mid-Atlantic" Steering Committee, the Chairman of the Northern Virginia Technology Council's Private Equity Committee, Co-Chair of the Program Committee for the Mid-Atlantic Venture Association ("MAVA"). Mark holds J.D. and M.B.A. degrees from the University of Pittsburgh and a B.A. degree from Allegheny College. Mr. Frantz was an NCAA All-American swimmer at Allegheny and has qualified for the USA Triathlon National Championship eight times.
_______________________
John Fraser
( Past President, AUTM; Assistant Vice President for Research and Economic Development, and Executive Director of the Office of IP Development & Commercialization, Florida State University )
Talking Points
US academic technology transfer is an enormous enterprise, engaging two hundred research universities and thousands of companies. This presentation will provide details of the scope and magnitude of the enterprise as well as examples of the success of the activity over a number of years in terms of companies started and products introduced into the marketplace to save lives, enhance the quality of life of patients and to increase the productivity and global competitiveness. A 1999 AUTM study showed that this activity has helped the private sector create over $ 32 billion in annual sales and an additional $ 8 billion in induced product development and supported 280,000 jobs.
Bio
Mr. Fraser is currently Assistant Vice President for Research and Economic Development, and Executive Director of the Office of IP Development & Commercialization, Florida State University, Tallahassee, Florida (1996-present). Prior to that he served as Director, University/Industry Liaison Office at Simon Fraser University, Vancouver, Canada. Mr. Fraser brings substantial corporate and university experience to the FSU position. He has held positions as Executive Vice President and co-founder of UTC, Inc., a venture capital backed, North Carolina-based university licensing/technology transfer firm; President and CEO of UTI, a University of Calgary based for-profit technology transfer company; Vice President of TDC, Inc., a Toronto and Vancouver-based venture capital firm and President, Burnside Development, a technology commercialization consulting firm. He has co-founded three companies and assisted entrepreneurs launch another twelve technology based firms. He is a member of the Board of Trustees of the technology transfer association AUTM, and served as its 2006 President. He is a Founding Board Director of the Tallahassee region technology association, the TalTech Alliance and its Executive Committee; is a Founding member of Board of the Florida Research Consortium and its Executive Committee, appointed by the Governor to increase university/company interactions to better the Florida economy; is a Member of the Board of BioFlorida, the statewide bio/life sciences trade association. Mr. Fraser holds a Masters Degree in Biochemistry from the University of California - Berkeley.
_______________________
Venky Ganesan
( Managing Director, Globespan Capital Partners )
Talking Points
VC's are from Mars and Entrepreneurs are from Venus. With my apologies to pop psychology, I will try to help explain how VC's are similar and different to entrepreneurs and how you can use that knowledge to better market yourself and eventually get funded by a VC. If you always wanted to understand how VC's think, why they ask the questions they do, and what they actually want to know - this is your talk.
Bio
Venky focuses on enterprise software and infrastructure investments. In addition to Palo Alto Networks, he is actively involved with Agitar, Amobee, Exeros, Jajah, Marketlive, Nominum, oDesk, Plaxo, and Strongmail. Prior to Globespan, Venky was the co-founder and Chief Operating Officer of Trigo Technologies, Inc. which was acquired by IBM in 2004. Previously, Venky worked with McKinsey & Co. in their Los Angeles and Johannesberg offices. He also was a program manager at Microsoft's Encarta group. Venky received degrees in Computer Science, Math, and Economics from both the California Institute of Technology and Reed College.
_______________________
Julie Gerstenberger
( Director, External Alliances, Eastman Kodak Company )
Talking Points
Representing the perspective of a strategic venture investor and potential customer/supplier for university start-ups, I will discuss how Kodak uses key university research partnerships to engage with the university startup ecosystem and to support mutually beneficial strategic alliances. I will also touch on how university licensing policies may promote or inhibit the growth of those startups.
Bio
Julie Gerstenberger is a Director, External Alliances at Eastman Kodak Company. Kodak External Alliances strengthens Kodak’s competitive position by seeking out and leveraging targeted strategic innovation, technology and intellectual property through alliances with universities, government laboratories and early-stage firms. Ms. Gerstenberger works with the Consumer Digital Group and Kodak Research Laboratories to create strategic partnerships that complement Kodak’s core competencies in Consumer Imaging, primarily through university research sponsorship and venture alliances/investments. Her current investment focus is on consumer imaging systems and services, including applications/devices, infrastructure and enabling technologies for consumer markets. Particular areas of interest include distributed media services and intelligent systems. Ms. Gerstenberger brings operational experience in the development and commercialization of digital imaging systems for a wide range of applications and markets, including some of Kodak’s earliest digital imaging systems. She holds an M.S. in Optics from the University of Rochester and a B.S. in Electrical Engineering from the University of Michigan.
_______________________
Shomit Ghose
( Partner, ONSET Ventures )
Talking Points
I will talk about how investors can begin an engagement with a university – surveying the field of opportunities, building relationships, and cultivating/developing promising ideas – based on my own experience in having funded multiple university-based startups. I will also talk about how universities can make it easier for investors to engage with them.
Bio
Shomit Ghose is a Venture Partner at ONSET Ventures, having joined the firm in 2001 after 19 years of working at high-tech companies in the Silicon Valley. During his operating career he worked at several successful start-ups, including Sun Microsystems, BroadVision, and Tumbleweed Communications. At ONSET, Shomit has worked closely in operational roles with portfolio companies in the software and networking sectors, and was also responsible for ONSET’s investments in Truviso, Ilial and Moteiv. Shomit is an Industry Fellow at the University of California, Berkeley, and has been active with entrepreneurial activities with a number of California universities. Shomit was awarded two academic scholarships to UC-Berkeley at age 15 and graduated in 1982 with a degree in Computer Science.
_______________________
Lawrence Gilbert
( Senior Director of Technology Transfer, Caltech )
Talking Points
The importance of an entrepreneurial culture in the creation of university start-ups. That plus critical mass are requisites for success in fostering start-ups.
Bio
Lawrence Gilbert is the Senior Director of Technology Transfer, of Caltech, the California Institute of Technology. The Office of Technology Transfer (OTT) provides a service to Caltech faculty members, other Caltech researchers, and Jet Propulsion Laboratory (JPL) technologists by protecting the intellectual property developed in their Caltech and JPL labs. The OTT fosters the commercial development of Caltech technologies in companies ranging from local start-ups to large, multi-national firms. Mr. Gilbert has been involved in the formation of more than 80 start-ups based upon or associated with university research. Several have gone public or have been acquired, and many have products in the marketplace. He acts primarily as a catalyst in putting the deal together, linking faculty, technology, and venture capital. Mr. Gilbert was formerly the Director of Patent Licensing for Massachusetts Institute of Technology (MIT). Prior experience includes Patent Consultant to various universities, including Boston University, Brandeis, Tufts, and the University of Massachusetts Medical Center and as the Director of Patent and Technology Administration of Boston University. Mr. Gilbert is a member of the Licensing Executive Society (LES) and a former Chairman of its Committee on Technology Transfer; and is a Founder of the former Society of University Patent Administrators, now known as the Association of University Technology Managers (AUTM). He is a member of the Executive Committee of the MIT/Caltech Enterprise Forum and formerly a member of the Board of Directors of the Southern California Biomedical Council and a former member of the Advisory Committee of the Business Technology Center, a high-tech incubator sponsored by the Los Angeles County Community Development Commission. Mr. Gilbert received his B.A. from Brandeis University; an MBA degree from the American Graduate School of International Management (Thunderbird); and a J.D. from Suffolk University; he is registered to practice before the U.S. Patent and Trademark Office (USPTO). Mr. Gilbert has been a frequent lecturer on patent and licensing matters and written several articles in the field.
_______________________
James Golubieski
( President, Foundation Venture Capital Group, LLC )
Talking Points
Foundation Venture Capital Group, an affiliate of New Jersey Health Foundation, was established to invest exclusively in technology coming out of the University of Medicine & Dentistry of New Jersey. What makes us unique is that, at this point, we are unaware of any other independent foundation that has created its own venture capital fund to invest pre-seed funding exclusively in a specific university’s start-up groups. During our session I will discuss the unique structure of our organization; why we established it; how we work with the Office of Patents and Licensing at the University and our due diligence process. I’ll also talk about the first organization in which we invested and those close to closing at this time.
Bio
James M. Golubieski is President of the Foundation Venture Capital Group, LLC, and the New Jersey Health Foundation. Both organizations support the growth of the University of Medicine and Dentistry of New Jersey. Mr. Golubieski had been CFO of Array Medical, Inc., a medical device company established in 1995 that developed a groundbreaking blood test to test platelet function. The company was sold in 1999. Previously, he was chief operating officer and senior executive vice president of Glendale National Bank and a member of its board of directors, president of Glendale Investment Corp. and Glendale Mortgage Services, Inc. and chief financial officer of Glendale Bancorp, which was acquired by Mellon Financial. For 10 years prior he had been with KPMG. He is a member of the New Jersey Society of Certified Public Accountants and the American Institute of Certified Public Accountants.
_______________________
Jo Anne Goodnight
( Acting Director, Division of Special Programs, Office of Extramural Programs, National Institutes of Health - NIH )
Talking Points
The NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are the best VC deal in town --a $650 million early-stage fund with no strings attached. This session will provide an overview of the NIH SBIR/STTR programs, including ways industry and academia can develop mutually beneficial partnerships for investigators seeking to commercialize their technology innovations. This session will provide an overview of the SBIR/STTR programs and will describe how entrepreneurial researchers can tap into this funding opportunity.
Bio
Ms. Goodnight currently holds the position as the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program Coordinator of the National Institutes of Health (NIH) and the Department of Health and Human Services (DHHS) Public Health Service. She is also serving as the Acting Director for the Division of Special Programs in the Office of Extramural Research (OER). Prior to joining OER in 1999, she served in positions encompassing research, program administration and program management. During her 25 years of Government service she has held positions in the U.S. Department of Agriculture (USDA), the Food and Drug Administration, and now the NIH. As part of her Virginia Tech education (1978-1983), she spent four years conducting research as a Cooperative Education student at the USDA’s Animal Parasitology Institute. While at NIH, she has been a part of the Intramural Research Program and the Extramural Research Program. As an intramural research scientist (1989–1994) at the National Cancer Institute (NCI), she published over 20 studies about the selective involvement of Protein Kinase C in differentiation and neoplastic transformation. In 1994, she transitioned to the NCI Extramural Research Program where she served as Special Assistant to the Director, Division of Cancer Biology and Program Director for SBIR/STTR grants that supported studies in the field of cancer biology, cancer genetics, and cancer immunology. In addition, she served as the NCI’s SBIR/STTR Program Policy Coordinator. She was appointed as the NIH/DHHS SBIR/STTR Program Coordinator in 1999 where she continues today. She was intimately involved in the development and implementation of the NIH SBIR/STTR Fast-Track Program and the SBIR/STTR Phase II Competing Renewal Award. She continues to develop other programs that assist the small business community in commercialization of their technologies. Ms. Goodnight has been an invited speaker at hundreds of SBIR/STTR Conferences. She also has provided written and oral testimony at Congressional hearings related to the reauthorization of the SBIR and STTR Programs. Her contributions to the SBIR/STTR programs and passion for helping small businesses to be successful in these programs have been acknowledged through several national awards including NIH Director’s Awards, NIH Merit Awards, and the Small Business Administration Tibbetts Award. Ms. Goodnight received a Bachelor of Science degree in Microbiology from Virginia Tech in 1983.
_______________________
Dan Gordon
( Director of Research, Valhalla Partners )
Talking Points
I would like to discuss "Silicon Valley vs. Washington DC: Two Data points on bringing innovation to market". Having lived in Silicon Valley from 1982-2000 and in DC from 2001-2007 (as well as growing up here), I’m in a position to draw some comparisons which I think are kind of interesting between the two environments.
Bio
Dan Gordon has twenty-nine years’ experience in the technology industry. Dan is currently Director of Research at Valhalla Partners, a Washington, DC venture-capital firm with more than $440M under management. At Valhalla, Dan is responsible for identifying emerging technologies and technology markets and for identifying innovations in universities and government labs. Prior to joining Valhalla Partners, Dan was a Director at the PricewaterhouseCoopers Global Technology Centre, a Contributing Writer and Contributing Editor to the Technology Centre's annual Technology Forecast, and a frequent speaker at industry and general business meetings. Prior to joining PwC, Dan worked in Silicon Valley as a software technologist, manager, director, and entrepreneur at companies such as Symantec, Oracle, and Intuit. Dan has a B.A cum laude from Harvard University and an M.S. degree from New York University in Computer Science. He is a Professional Member of the ACM. Dan lives in Washington, D.C. with his wife and two children.
_______________________
Tony Grover
( Managing Director, RPM Ventures )
Talking Points
Tony will discuss different models and approaches to funding university spinouts. His remarks will include insight and background on how researchers can attract entrepreneurial managers and venture capitalists to start and fund their companies as well as explaining these individual’s roles and involvement before and after their organization receives funding.
Bio
Tony Grover is managing director of RPM Ventures, a seed and early stage venture capital firm based in Ann Arbor, Mich. During his career, Grover has worked both from the venture capital side by driving investment in a number of university spinouts, and from the entrepreneurial side, as co-founder of an Internet company. Grover has also received finance, engineering and manufacturing experience with Intel Corporation and Cummins Engine Company. Grover also serves on the board of the University of Michigan Frankel Commercialization Fund and the Michigan Universities Commercialization Initiative (MUCI) Challenge Fund. He holds a Bachelor of Science in mechanical engineering from the University of Michigan, a Master of Science in industrial engineering from Purdue University, and a Master of Business Administration from the J. L. Kellogg Graduate School of Business.
_______________________
Mark Grovic
( Founding Partner and Managing Director, University of Maryland, New Markets Fund )
Talking Points
I will describe the particular approach we took to raising and investing our $25M venture fund that is independent from, but located at, the University of Maryland. Our relationship with the entrepreneurship center, incubator and tech transfer offices at the University of Maryland, and other local Universities, has greatly contributed to our success. We also teach an award winning, highly selective class to MBA candidates, law students, and graduate life science and engineering students who serve as Associates for the Fund.
Bio
Mark is a Founding Partner and Managing Director of the New Markets Growth Fund (NMGF), a $26 million venture capital fund focused on high-growth technology companies and housed at the University of Maryland, College Park (UMCP). Mark serves or served on the Board of Directors of Lightningcast (sold to NYSE: TWX), Innovative Biosensors, and Artifact Software, and is a board observer for Biosurface Engineering Technologies, BD Metrics, and Paratek Microwave, all of which are NMGF portfolio companies. Mark is also the Venture Capitalist in Residence for the R.H. Smith School of Business at UMCP, where he is a Professor of Venture Capital and Entrepreneurship. In 2004, he received the US Association of Small Business and Entrepreneurship National Outstanding Course Award for Excellence in Entrepreneurship in Education. Mark is also a Partner in Smith Advisory and Collaborative Services, a Senior Fellow in the Executive Education Department, and teaches in the UMCP Executive MBA program. Mark currently sits on the Investment Committee for the Maryland Technology Development Corporation (TEDCO), is Co-Chair of the NASA Goddard / UMCP Technology Transfer Initiative, is on the Business Review Panel for UMCP’s Technology Advancement Program (TAP) Incubator, the Incubator Company of the Year Award Committee, UMCP Inventor of the Year Selection Committee, National Collegiate Inventors and Innovators Alliance Grants Review Committee, and the US DOC’s Minority and Business Development Associations Steering Committee for minority access to capital. He is a frequent speaker at conferences and guest lecturer, and has been a regular contributor to domestic and international publications. Mark graduated Cum Laude from the University of California, Berkeley, in 1989 where he majored in international politics and economics. In 1994 he received a Juris Doctor from the Georgetown University Law Center, where his focus was in international, tax, and corporate law. Mark has also completed graduate work in accounting and finance at the George Washington University School of Business and Public Management in Washington, DC, and at Pace University in New York City. Mark is married and has two children.
_______________________
David Gulley
( Associate Vice President for Technology and Economic Development, University of Illinois )
Talking Points
For more than five years, the University of Illinois has invested in developing and refining its practices to increase technology commercialization on its campuses in Chicago and Urbana-Champaign. It begins with the Offices of Technology Management and robust disclosure screenings and investments in patenting; to IllinoisVENTURES and its start-up practices, including seed and follow-on funding; and finally to incubation facilities and research parks adjacent to both campuses. There are new regional collaborations with other research institutions and corporate partners that leverage research strengths to connect academic-industry opportunities.
Bio
David L. Gulley, is Associate Vice President for Technology and Economic Development for the University of Illinois system. He also serves as Assistant Vice Chancellor for Research and Interim Director of the Office of Technology Management at the University of Illinois at Chicago. Since 1989, he has provided leadership in the University’s technology-based economic development activities that include academic-industry partnerships and technology commercialization. Gulley is active with Illinois’ technology community, recently serving on the Executive Committee for BIO2006 and leading BIO’s Academic-Industry Committee; BIO’s Technology Transfer Committee; and co-chair of iBIO’s 2007 Life Science Industry Expo and Marketplace (IndEx 2007). Gulley is also active with the Association for University Technology Managers (AUTM), serving on the Best Practices Task Force and as Graduate Course Chair. He holds a BA and PhD from Southern Illinois University and a Master’s graduate degree from Virginia Tech.
_______________________
Jim Gunton
( Co-founder, NJTC Venture Fund )
Talking Points
I will discuss NJTC Venture Fund's experience and perspective as early stage Venture Capitalists in evaluating multiple University-sponsored opportunities with the focus on "why" we chose to make the investments we did.
Bio
Mr. Gunton has been investing in privately-held growth technology companies for nearly 15 years. Before co-founding in 2001 the $80 million NJTC Venture Fund, Gunton was a manager at Oracle Corporation in the Silicon Valley. He represents NJTC Venture Fund at nine portfolio companies and is a Governor of the National Association of Small Business Investment Companies. Jim earned a BS from Stanford University and an MBA with distinction from Duke University.
_______________________
Robert Hacker
( Florida International University )
Talking Points
At FIU we have run business plan competitions and boot camps for four years. During this time the single biggest issue has been helping the students turn classroom theory into the practical requirements of a financeable business plan. For this reason we encourage local entrepreneurs to attend the boot camps and rely more and more on practioners to provide the boot camp content.
Bio
I am an Adjunct Professor at FIU where I teach entrepreneurship to undergraduates. I have been a business plan competition judge at FIU for three years and have offered boot camp sessions on the financial plan for two years. I manage a boutique investment bank in Miami that provides capital raising and financial consulting services to early stage and middle market companies in Florida, the Caribbean and Central America. Prior to returning to the U.S. in 1999, I ran a public company in Indonesia that grew from $40 million to $1 billion in annual revenue in seven years.
_______________________
Christopher Hayter
( Director, Economic Development Program, National Governors Association - NGA, Center for Best Practice )
Talking Points
I will be talking about the increasing attention that governors are giving to public-private partnerships, including with universities, to promote innovation, local university startups and entrepreneurship within and among states.
Bio
Chris Hayter is the Program Director for Economic Development at the National Governors Association Center for Best Practices. Chris is staff lead for the NGA Innovation America initiative, led by GovernorJanet Napolitano of Arizona, which seeks to help governors encourage entrepreneurship, improve math and science education, and better align post-secondary education with state innovation needs. Prior to this appointment, Chris served as Research Director for the National Council for Advanced Manufacturing (NACFAM), where he proposed and managed research project in technology and product development, and supply chain integration. He held similar positions with both the Council on Competitiveness and the National Academies' Board on Science,Technology, and Economic Policy. Previous experiences include resort management, bartending, and teaching English in the Czech Republic. Chris is a graduate of the U.S. Coast Guard Academy where he earned his Bachelor of Science in Industrial Engineering and Public Policy,completed an M.A. in International Science and Technology Policy from the George Washington University, and is currently a Ph.D. Candidate in Economics and Technology Policy.
_______________________
Chip Hazard
( General Partner, IDG Ventures Boston )
Talking Points
I will speak about best practices in starting a technology driven university spin out including case studies of companies that have successfully made this transition and the lessons learned from each.
Bio
Chip is a General Partner at IDG Ventures Boston whose investment interests and experience are in information technology with a focus on enterprise software. He currently represents IDG Ventures Boston on the boards of 1-800-FREE411 (Jingle Networks), Infobright, mValent, Placemark Investments, Reveal Imaging, and SupplyScape and was previously a director at Bowstreet, which was acquired by IBM. He also serves on the boards of Idiom and NewView Technologies. Before joining IDG Ventures in May 2002, Chip was a General Partner with Greylock, a leading national venture capital firm he joined in 1994. While at Greylock, Chip led or participated in numerous sucessful investments in the enterprise information technology field including Narrative Communications (acquired by @Home), iPhrase Technologies (acquired by IBM), IBA (acquired by ServiceSoft/Kana), Storage Networks (IPO), Totality (acquired by MCI) and the Vincam Group (IPO in 1996, acquired by ADP). Prior to Greylock, he was with Company Assistance Limited, an investment and consulting firm in Warsaw Poland; and Bain and Company, an international management consulting firm. Chip received a BA with honors from Stanford University and an MBA from Harvard Business School where he was a Baker Scholar and a Ford Scholar.
_______________________
Mark Heesen
( President, National Venture Capital Association )
Talking Points
The current state of the venture capital industry: what technologies and geographic regions are getting funded; what the future holds for venture capital; how corporate VCs are coming back into the process; the growth in early stage investing, and how public policy, venture capital and entrepreneurship intersect.
Bio
As President of the National Venture Capital Association, Mark Heesen is responsible for setting the strategic direction for all Association activities, including public policy efforts, research initiatives, educational programs, and member services. In this capacity, Mark works closely with the NVCA professional staff and Board of Directors to demonstrate the positive impact of venture capital investment on the United States economy. Under his direction, the NVCA has created numerous value-added sub-groups including the CFO Task Force, Strategic Communications Group, Corporate Venture Capital Group, Medical Industry Group and Human Capital forum, all of which are dedicated to supporting NVCA membership in uniquely critical areas. As a spokesperson for the venture capital industry, Mark is often called upon by the financial media, NVCA members, limited partners, and regional associations to present the overarching venture capital perspective to a wider audience. He is a frequent presenter at industry conferences, appears regularly on CNBC, and is consistently quoted in the press in stories concerning venture capital trends. Since 1991, Mark has worked on behalf of the NVCA to enact a wide range of policies that benefit the venture capital and entrepreneurial communities, including a significant capital gains differential, securities litigation reform, numerous SEC and FASB accounting issues, immigration reform, and a streamlining of the FDA and CMS approval processes, among other issues. Prior to coming to the NVCA, Mark was an aide to a former Governor of Pennsylvania and was Deputy Director for Federal Funds reporting to the Texas Legislature. Mark received a law degree with an emphasis in taxation from the Dickinson School of Law in 1984.
_______________________
Joe Hernandez
( President and CEO, Innovative BioSensors )
Talking Points
Where did the technology originate? How did you and your organization secure it? How did you fund the initial acquisition of the technology and start-up of your business? What were the steps you took to move your product along in development? When did you commercialize your first product? What steps did you take to move from R&D to commercialization? What follow-on funding did you acquire and how? Where is your technology now? Is it revenue producing? What are your plans for the future of your current technology or the acquisition of others? What lessons have you learned and would you do it differently if you could?
Bio
Mr. Hernandez obtained a Bachelor of Science degree in Neuroscience and graduate degrees in Molecular Genetics and Business Administration from The University of Florida. He has been published in several highly-respected scientific journals and presented at numerous scientific meetings. He has held senior level marketing, sales and business development positions at Digene Corporation, Affymetrix, Inc., and Merck. Mr. Hernandez has successfully launched numerous products in the pharmaceutical, research and diagnostic markets. He has in-depth knowledge of market research, competitive analysis and business development.
_______________________
G Duncan Hitchens
( Vice President, Lynntech, Inc. )
Bio
Dr. Hitchens received a B.Sc. Degree in Bacteriology (1981), and a Ph.D. Degree in Microbial Physiology (1985) from the University of Wales, after which he carried out post-doctoral research in electrochemistry at Texas A&M University. Dr. Hitchens is co-founder of Lynntech Inc. and has been its Vice President since 1991. Based in Texas, Lynntech Inc. is a leading technology development and technology commercialization company, with annual revenues of $15 million. Dr. Hitchens is co-inventor on over 20 patents, has received 5 NASA Certificates of Recognition, has co-authored over 40 scientific publications and has made numerous technical presentations. He currently oversees 40 scientists and product development engineers, emphasizing technology marketing to corporate clients and establishment of strategic partnerships. His work has led to several licenses to leading companies in the fields of consumer products, infection control and fuel cell power sources. He currently oversees early-stage technology development programs valued at over $5 million annually. Recently, he established Lynntech’s Technology Transfer Office in Richardson, Texas, with the goal of promoting collaborative activities between Lynntech Inc. and the Dallas/Fort Worth University research community.
_______________________
Richard Holdren
( Healthcare Angels )
Bio
Co-Founder of Equivision, publicly traded on NASDAQ and sold for over 70 million cash, and EquiMed a publicly traded cancer management company with a market cap over $200 million, Rick has additionally co-founded/Invested in Physician Trust (venture backed by over 5 million in investment), DaVincian Technologies (picked by Bob Ryan’s High-Tech Start-up Boot Camp), Austin Med Tech a publicly traded surgical ‘pack’ company, DermAmerica, a national cosmetic dermatology firm & MD Pain Clinics. As a serial entrepreneur Rick has founded or invested in over 26 healthcare start-ups and named as 2002 Center for Entrepreneurship & Innovation Mentor of the year. Rick also was a partner in the nation’s largest physician search firm, a director of physician relations at a major hospital management firm and co-founder of Texas’s largest practice management firm. He currently owns Appraisal & Mentor Group LLC, which is a top 3 M & A and healthcare valuation firm with over 2500+ completed assignments including over 200 court valuations. He made an investment is a ‘virtual incubator’ with ‘space-act’ agreement with NASA to commercialize its phase III SBIR companies with matching venture investment.
_______________________
Greg Horowitt
( Co-founder and Executive Director, UCSD Global CONNECT )
Bio
Greg Horowitt is the co-founder and Executive Director of Global CONNECT, based at the University of California, San Diego. He is a key thought leader in the field of ‘innovation systems’, and their relevant applications for sustainable regional economic development through technology commercialization. In addition, Greg is also the founding Managing Director of T2 Venture Capital; a seed stage venture firm focused on the commercialization of intellectual property out of leading research institutions, (academic public, and private), and government funded agency programs. Prior to founding Global CONNECT, Greg was the interim Director of the regional CONNECT program in San Diego. Greg’s background has been in executive management, where he held key positions at a Berkshire Hathaway company for nearly 20 years, served as an Entrepreneur-in-Residence at a leading Silicon Valley venture capital firm, and was the CEO of a venture-backed enterprise software company.
_______________________
Tim Howe
( Founder, CHL Medical Partners )
Talking Points
I will talk about sustaining long-term productive relationships between venture capitalists and technology transfer offices.
Bio
Tim is a founder of CHL Medical Partners, a leading healthcare venture capital group based in Stamford, CT focused on start-up and early stage investing in the biotechnology, medical device and services areas. Tim has been investing in private equity since 1984 when he joined Schroder Ventures. He has been an active investor and board member responsible for numerous venture investments in the healthcare space, including Innotech, Inc. (acquired by Johnson & Johnson), Camitro Corporation (acquired by ArQule, Inc.), and Alexion Pharmaceuticals, Inc. CHL has led the start-up of many companies directly from university settings, including CGI Pharmaceuticals, Inc., Amicus Therapeutics, Inc. (NASDAQ “FOLD”), Protometrix, Inc. (sold to Invitrogen), and BioRelix, Inc. Tim has been a director of nineteen companies and is currently on the boards of Bionaut Pharmaceuticals, Inc., Comprehensive NeuroScience, Inc., Medicus Insurance Holdings, Inc. and MedMark Services, Inc. He is also an Adjunct Assistant Professor at Columbia Graduate School of Business teaching venture capital management. Tim is a graduate of Columbia College and the Columbia Graduate School of Business. Tim can be reached at thowe@chlmedical.com.
_______________________
Eva Jack
( Associate Director of Business Development, Medimmune )
Talking Points
Where did the technology originate? How did you and your organization secure it? How did you fund the initial acquisition of the technology and start-up of your business? What were the steps you took to move your product along in development? When did you commercialize your first product? What steps did you take to move from R&D to commercialization? What follow-on funding did you acquire and how? Where is your technology now? Is it revenue producing? What are your plans for the future of your current technology or the acquisition of others? What lessons have you learned and would you do it differently if you could?
Bio
Eva M. Jack, Associate Director of Business Development, MedImmune, Inc. In her role at MedImmune, Ms. Jack is responsible for business development activities with academic and medical research institutions. Her responsibilities include identifying new and interesting research opportunities in the therapeutic areas of oncology, infectious diseases and immunological and inflammatory diseases. This includes in-licensing as well as research collaborations. Prior to MedImmune, she was at Intel Corporation for 13 years and held a variety of positions in the company. Her last job was in Intel Capital, the venture fund of the company, and was responsible for investments and research collaborations in biotechnology and health care. She was also the Technical Assistant to the Vice President of Human Resources. In this capacity, she played an integral role in the strategic planning process for the organization. Eva began her career as a lobbyist in Washington D.C. covering a variety of areas including health care, immigration, labor law and education and training. In this capacity she was responsible for developing Intel’s position on these public policy concerns. Ms. Jack holds a B.A. from the University of Virginia and a M.H.S. from Johns Hopkins University.
_______________________
Andrew Jay
( Head of Medical Solutions, Siemens Venture Capital )
Talking Points
Bio
Dr. Andrew Jay is Head of the Medical Solutions Fund at Siemens Venture Capital. Since initiating the Fund in late 2002, he has closed several investments in the medical technology and pharmaceutical arenas. Two notable IPO’s in his portfolio are Animas, a maker of external insulin pumps, and Molecular Insight Pharmaceuticals, a company developing imaging agents for cancer and cardiovascular applications. He currently is on the Board of Directors of Molecular Insight Pharmaceuticals, U-Systems, and Vasomed. He is a Board Observer at MDdatacor, and involved with Sequenom and Cylex. Dr. Jay previously was a medical technology analyst leading the practices at Wachovia Securities, Alex. Brown and Deutsche Bank Securities. Sectors under coverage included imaging, orthopedics, cardiovascular, vision, diabetes, diagnostics and neurologic devices. During his career as an Institutional Investor ranked analyst, he was commended for his stock picking acumen and industry expertise by numerous publications. He was instrumental in raising over $2 billion in equity capital for a multitude of companies and published over 10,000 pages of research and bringing over 20 medical technology companies public. He was frequently quoted and interviewed in the financial trade press including the Wall Street Journal, Investors Business Daily, CNN and MSNBC. He distinguished himself with thought-leading research on topics such as neurological devices, stroke, and the first major report on the enormous opportunity in coated stents. Prior to his time in the financial community Dr. Jay's experience includes leading healthcare consulting projects for Arthur D. Little and running his substantial dental practice. He has a Bachelor of Science from Rensselaer Polytechnic Institute, a DMD from the University of Pennsylvania and an MBA from the Kellogg School at Northwestern. Outside of the office Andrew is active in the restoration and preservation of historic Charlestown, Massachusetts where he is a Director of the Friends of City Square Park. He has also served as a Director of The Epilepsy Foundation.
_______________________
Zach Jonasson
( Seaflower Ventures )
_______________________
Greg Jones
( CEO, VisTrails, Inc., and Former State Science Advisor, Utah )
Talking Points
I will share my experiences on moving technologies from universities to the market place and on aligning state-sponsored programs with other federal and university programs that aid the entrepreneur.
Bio
Dr. Jones received his bachelor’s degree in Physics from the University of New Mexico in 1988. He also earned his doctoral degree from the University of New Mexico in Biomedical Science. Between degrees, he was an optical engineer with CVI Laser Co. in Albuquerque, New Mexico, specializing in optical testing and optical instrument design. From 1997 to 1999, he was a post-doctoral fellow at the University of Utah in the Department of Radiology where he was a member of the Functional Brain Imaging Group. He later joined Storage Technology Inc. (StorageTek) as a principal consultant in the Medical Group. In 2000, he became Associate Director of the Scientific Computing and Imaging (SCI) Institute at the University of Utah from which he co-founded university technology spin-off, Visual Influence. Visual Influence a visualization software firm was acquired in 2007. In 2005-2007 Dr. Jones served as the State Science Advisor for Utah Governor Jon Huntsman. Currently, Dr. Jones is the executive director of research for the Moran Eye Center at the University of Utah and CEO of university spin-off VisTrails, a software company founded in 2007 specializing in workflow and data provenance management tools.
_______________________
Timothy Keane
( Entrepreneur in Residence, Marquette University )
Talking Points
I will talk about the MU angel network description (80 members, two cities, deal screening and management process) and big two or three learnings over the four years we've been doing it.
Bio
Timothy J. Keane is the Entrepreneur in Residence at Marquette University in Milwaukee, Wisconsin. Prior to accepting this appointment in 2001, he was the founder and CEO of Retail Target Marketing Systems, Inc., a software company. The company was sold in 2000 and is now a unit of Metavante, a publicly traded banking services company. In his current position he manages the University based Marquette Golden Angels; teaches graduate and undergraduate courses; and is the director of the newly formed center for Cross Campus Entrepreneurship and Innovation. This new initiative was founded to bring entrepreneurial education to all of the University’s students, regardless of major field of study. His blog about advice for entrepreneurs is at www.timkeane.org. He is a director of the Angel Capital Association in Washington, DC. a director of First Business Bank, and a director of the Frank Lloyd Wright Foundation’s Preservation Society. Before founding Retail Target Marketing Systems, Inc. in 1989, he was the manager of worldwide marketing communications for GE Healthcare with offices in Frankfurt, Madrid, London and Amsterdam. He is a graduate of Seattle and Marquette Universities.
_______________________
Todd Keiller
( Director, Technology Transfer, University of Vermont )
Talking Points
My remarks will focus on how a smaller academic institution can fill the gap between basic research and applied research. The University of Vermont has created UVM Ventures which provides a continuum of funding for projects that have a commercial potential. It has been designed in a way to maximize the probability of appealing to funding sources or licensees beyond UVM. UVM Ventures has a unique funding composition of internal, state, and philanthropy funding. It is an example of how a smaller institution in a remote location can still attempt to move technology forward through the development cycle.
Bio
Mr. Keiller is the Director of Technology Transfer for the University of Vermont. He also handles the technology transfer for Maine Medical Center, Caritas St. Elizabeth’s Medical Center of Boston, and Boston Biomedical Research Institute. He has worked for 16 years in the industrial sector in a variety of sales, marketing, and business development roles, 10 of which were with Corning. He has over 17 years of academic licensing experience and is the former Vice President, Ventures of the Brigham and Women’s Hospital in Boston. Todd has contributed to the founding of 7 companies in the life sciences field. He holds an AB from Dartmouth College and an MBA from the Tuck School of Business Administration.
_______________________
JP Kim
( Director & Policy Officer, Division of Extramural Inventions & Technology Resources (DEITR), Office of Policy for Extramural Research Administration (OPERA), Office of Extramural Research (OER), National Institutes of Health )
Talking Points
NIH is the steward of medical and behavioral research for the Nation. As the federal government’s foremost sponsor of biomedical research, NIH is interested in furthering research to benefit the public and accelerating the pace of how research results reach the public. The NIH Office of Extramural Research (OER) is the primary point of contact for NIH funding recipients for policies and related guidance, as well as for program coordination, compliance, and electronic research administration for research and training programs conducted through extramural (grant, contract, cooperative agreement) programs. To enhance research endeavors in the community, OER provides information, resources, and outreach to help the community identify NIH funding opportunities, areas of research, and potential collaborators, and to help the research community better understand and comply with the federal requirements and policies associated with federal funding. Such resources include the NIH Guide for Grants and Contracts, Computer Retrieval of Information on Scientific Projects (CRISP), iEdison, and others.
Bio
Mr. Kim serves as Director and Policy Officer of the Division of Extramural Inventions & Technology Resources (DEITR) in the Office of Policy for Extramural Research Administration (OPERA) under the Office of Extramural Research (OER) at the National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services (DHHS) and the Public Health Service (PHS). Prior to joining OER in 2005, he served for 10 years in the Office of Technology Transfer under the NIH Office of Intramural Research (OIR) as a Technology Licensing Specialist, Patent Advisor, and Technology Transfer Policy Specialist for inventions arising out of the NIH’s Intramural Research Program. Prior to coming to the NIH, he worked as a Cancer Researcher at the George Washington University Medical Center and School of Medicine and Health Sciences, as well as a Researcher at several biomedical/biotechnology companies in the Washington-Metropolitan area. In addition to direct research experience, he has also worked as a scientific/technical consultant on domestic and international patent and trademark prosecution matters at various national and international intellectual property law firms. He is an attorney admitted to practice before the U.S. Patent and Trademark Office (USPTO) of the U.S. Department of Commerce, the Maryland courts, the U.S. Court of International Trade, the U.S. Court of Appeals for the Federal Circuit (CAFC), the Supreme Court, and other courts, and has published articles on technology transfer and research issues in scientific, business, and grants management publications. He holds a B.A. (Psychology) and a B.S. (Zoology with Chemistry minor) from George Washington University, an M.B.A. (International Business and Marketing) and a J.D. (focusing on International Trade and Intellectual Property Law) from American University, an M.Sc. (Biotechnology) from Johns Hopkins University, an M.A. in Liberal Studies with a focus on Social/Public Policy from Georgetown University, as well as having additional graduate study in genetics, EU law, management, and public policy.
_______________________
Steve Kozak
( President, Greater Baltimore Technology Council )
Talking Points
Created by the Greater Baltimore Technology Council (GBTC) in 2002, MoshPit! provides an opportunity for students from Maryland colleges and universities to experience every aspect of starting a business. Student participants learn how to form a qualified team, write a competitive and realistic 2-5 page business plan, and present their ideas in a concise and clear format. And of course, there are the cash prizes – a total of $30,000 for the winning teams. Why participate? It’s fun and it provides the ‘real world’ experience that looks great on a resume. Additionally, besides the practical knowledge the experience brings, students will also make connections with some of Maryland’s top tech entrepreneurs, businesspeople and venture capitalists who will act as your “advisors” as you develop your business plans. These individuals can be an invaluable resource in a post-graduation job search or business launch. And, candidly, you never know where this experience will take you. At the very least, you'll be better positioned to launch that business down the road.
Bio
Steve Kozak became Executive Director of the Greater Baltimore Technology Council (GBTC) in March 2005 after serving as the GBTC’s Assistant Director since June 2001. During Steve’s tenure as Executive Director, the GBTC has grown substantially. Today, the organization offers more than 200 programs, forums and roundtables, while membership has jumped nearly 23 percent over the past two years. As Executive Director, Steve has been instrumental in expanding and strengthening collaborations with other regional business and technology organizations. Under his direction, the GBTC forged a strategic alliance with the Tech Council of Maryland, helping to advance Maryland’s national stature as a hotbed for technology growth. The GBTC has also continued to provide member-driven programs and forums where people meet, learn and do business, while spreading the word that technology and the entrepreneurial spirit thrive in Greater Baltimore. Many of those programs – including such major initiatives as MoshPit and TechNite – have been recognized both locally (The Daily Record’s Innovator of the Year Award) and nationally (The Public Relations Society of America’s Silver Anvil Award). Steve has also been responsible for launching a number of new initiatives, including GBTechNet, the GBTC Golf Classic, networking events such as the GBTC’s regular Wine Tastings (winner of Baltimore Magazine’s Best Places to Network Award) and a series of Executive Roundtables. A member of the UMBC President's Advisory Council (PAC) and Emerging Technology Center’s Board of Directors, Steve is known throughout the region’s business community for the passion he brings to his post. He believes in the GBTC and in its mission to grow Greater Baltimore’s tech community. His enthusiasm has earned the respect of the GBTC’s members, its board, and the leadership at the Maryland Department of Business and Economic Development (DBED), the GBTC’s funder and partner. Prior to joining the GBTC, Kozak was Director of Business Development for Gilden Integrated, a Baltimore area ad agency. Previously, he held positions as a business analyst, product manager, and marketing manager for PHH Vehicle Management Services in Hunt Valley, Maryland. Kozak earned his bachelor’s degree in marketing from the University of Maryland, College Park and an MBA from Loyola College.
_______________________
Steven Kubisen
( Senior Director, Johns Hopkins University )
Talking Points
Johns Hopkins University is the largest research institution in the country and is located in Maryland, which leads the nation in research funding. To better unlock the potential for innovation into various commercial markets, we must continue to grow our university’s and the region’s capacity for developing new ventures. This panel will discuss a developing private/public partnership between private angel investors, private and public research institutions, and state agencies to grow the support for early stage technology ventures in greater Maryland.
Bio
Steve joined Johns Hopkins Universit